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COMPLICATIONS AND LENGTH OF STAY FOLLOWING SPINE SURGERY: ANALYZING 
LOCAL AND NATIONAL COHORTS 
Jordan A Gruskay, Jonathan N Grauer. Department of Orthopedics, Yale School of Medicine, New Haven, 
CT  
 
Complications following spine surgery are widely reported but poorly characterized. The effect of 
preoperative comorbidities and postoperative complications on length of stay (LOS) has not been 
evaluated. It would be ideal to have a clearer understanding of the variables affecting LOS to facilitate 
setting expectations and control costs. Using complications and LOS as outcomes, we can also characterize 
the risks inherent with surgical practices, such as the use of iliac crest bone graph (ICBG) in spinal fusion. 
The study consisted of three aspects. First, the effect of pre and perioperative variables on LOS for 103 
patients undergoing posterior lumbar fusion at Yale was examined. Next, the National Surgical Quality 
Improvement Program (NSQIP) database was used to determine the variables associated with extended 
LOS and complications following 2,164 anterior cervical discectomy and fusion (ACDF) procedures. 
Finally, 13,927 spinal fusion cases from the NSQIP database were analyzed to determine the effect of 
harvesting ICBG on operative time, complications, LOS, and readmission. Multivariate analysis was used 
throughout the study to control for confounding while evaluating statistical significance.  
 For lumbar fusion, average LOS was 3.6 ± 1.8 days. 79% had a stay of four days or less. Preoperative 
variables associated with increased LOS were age and ASA score. Heart disease was significantly 
associated with decreased LOS. Postoperative complications occurred in 32% of patients and led to a LOS 
of 5.1 ± 2.3 days vs. 2.9 ± 0.9 days for patients with no complication. For ACDF, average LOS was 2.0 ± 
4.0. Age ≥ 65, functional status, transfer from facility, preoperative anemia, and diabetes were the 
preoperative factors predictive of extended LOS. Major complications, minor complications, and extended 
surgery time were the perioperative factors associated with increased LOS. 71 (3.3%) had a total of 92 
major complications. ASA score ≥ 3, preoperative anemia, age ≥ 65, extended surgery time and male 
gender were predictive of major complications. Meanwhile, postoperative blood transfusion (OR 1.5), 
extended operative time (+ 22.0 min) and LOS (+0.2 days) were significantly associated with ICBG use. 
After lumbar fusion, patients that are older and have widespread systemic disease tend have longer 
LOS, but no single comorbidity was predictive of LOS. After ACDF, 1 in 33 patients develops a major 
post-operative complication, which are associated with an increased LOS of 5 days. Current ICBG usage in 
spinal fusion is low, with rates between 3.4% and 12.4% depending on approach.  Use of ICBG is 
associated with extended operative time, extended LOS, and postoperative blood transfusion.  
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Introduction: 
Complications following spine surgery are widely reported but often poorly 
characterized. The patient and procedure specific factors leading to these complications 
are rarely considered. Meanwhile, complications and postoperative length of stay (LOS) 
are closely related outcomes, with postoperative complications often requiring additional 
medical or surgical management leading to a longer LOS. In the spine literature, LOS is 
an outcome often used in the comparison of two cohorts. However, the effect of 
preoperative comorbidities and postoperative complications with LOS as the dependent 
variable has not been considered. 
LOS is important from a patient perspective, and is an important factor in 
determining health care costs in patients undergoing surgery. Costs associated with each 
additional day in the hospital are near $1,000, 1 and inpatient hospital charges (excluding 
implant or surgical charges) have been linked with LOS. 2 
LOS is important to consider for reasons other than cost, such as optimizing 
patient experience. Preoperative counseling before orthopedic procedures has been shown 
to reduce patient stress and hospital stay. 3 Further, increased LOS has been associated 
with adverse outcomes such as hospital acquired infections 4,5 and deep vein thrombosis 
(DVT). 6-8 It consumes physician and housestaff time and decreases the potential for 
additional surgical volume. Knowledge of the factors determining increased LOS can 
help surgeons guide treatment and preoperative expectations, and help patients plan 
postoperative care.  
Using complications and LOS as outcome measures, we can also characterize the 
risks inherent with certain surgical practices and procedures, such as the use of iliac crest 
	  	  
2	  
bone graph (ICBG) in spinal fusion. ICBG is still considered the “gold standard” in 
grafting for progression of spinal fusion due to its osteoconductive, osteoinductive, and 
osteogenic properties. 9-11 However, morbidity associated with the harvest of ICBG is of 
clinical concern and has lead to significantly decreased usage over the past decade with 
the invention of artificial bone graft substitutes.  
Postoperative donor-site pain is a commonly reported issue, 12-14 15-18 although 
may be overstated. 13,19,20 Other issues include hematoma, infection, pelvic fracture, and 
nerve palsy. 14,17,21 Increased blood loss, operating time and anesthesia time associated 
with the harvest procedure add additional risk. 21-24 Due to the above issues, patients 
receiving ICBG are at a risk for prolonged LOS. Several studies have reported differing 
results on increased LOS following ICBG harvest in spine surgery, although multivariate 
analysis has not been performed. 19,21-26  
Analysis of many postoperative complications can be difficult due to their relative 
rarity. Additionally, characterization of ICBG is becoming more challenging in modern 
clinical practice due to the decreased utilization of this practice. The use of a national 
database can allow for adequate numbers to support the analysis of rare complications 
and practices. The National Surgical Quality Improvement Progam (NSQIP) is a national 
database that captures clinical information and 30-day postoperative outcomes. Despite 
its shortcomings, including the lack of some procedure specific variables, it allows for 
investigators to perform large-scale multivariate analyses of rare events with greater 
power than smaller cohort studies are able to generate.  
Ultimately the goals of this study are threefold: use multivariate analysis to 
examine LOS and complications following spine surgery in a local cohort, to examine 
LOS and complications following spine surgery in a national database, and to examine 
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the risks of using ICBG in spinal fusion with LOS and postoperative complications as the 
primary outcome variables. We hope that the findings in this study provide spine 
surgeons with useful information for setting preoperative patient expectations and for 
decision making with regards to patient selection and bone grafting methods. 
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Part 1: Factors Affecting Length of Stay Following Elective Posterior Lumbar Spine 
Surgery: A Multivariate Analysis 
Abstract: 
Introduction: 
Elective posterior lumbar fusion is a common surgical procedure, but reported 
length of hospital stay is variable (usually 3-7 days). The effect of individual or select 
few factors on LOS has previously been evaluated. However, multivariate analysis using 
LOS as a dependent variable in order to separate potentially confounding variables has 
not been performed.   
Purpose:  
To facilitate setting of realistic expectations and considering the significant costs 
of hospitalization, it would be ideal to have a clear understanding of the variables 
affecting length of stay (LOS) for this surgery. 
Methods: 
Records for 103 patients undergoing elective, open 1-3 level posterior lumbar 
instrumented fusion (with or without decompression) by the orthopedic spine service at 
our institution between January 2010 and June 2012 were queried. LOS was determined 
from the date of surgery to the date of discharge. Preoperative factors (patient 
demographics, previous surgery, levels instrumented, American Society of 
Anesthesiologists (ASA) score, and major medical comorbidities including diabetes, 
hypertension, malignancy, pulmonary disease or heart disease); intraoperative factors 
(complications, drain placement, estimated blood loss, blood transfusion, fluids 
administered, operating room time, and surgery time); and postoperative factors (drain 
removal, blood transfusion, complications, and discharge destination) were collected and 
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analyzed with multivariable stepwise regression to determine predictors of LOS. 
“Postoperative complications” was excluded as an independent variable from the 
regression analysis because of its close relationship with LOS.  
Results:  
Our sample included 70 one-level, 26 two-level, and 7 three-level operations. 
Average LOS was 3.6 ± 1.8 days (mean+SD) with the range 0-12 days. Of this cohort, 
79% (81 of 103) had a stay of four days or less. The only preoperative variables 
associated with LOS in the multivariable model were age (p = 0.038) and ASA score (p = 
0.001). History of heart disease (p= 0.005) was significantly associated with a decreased 
hospital stay. 
Intraoperative complications included six dural tears and one pedicle fracture. No 
intraoperative factors were found to be associated with a longer LOS. 
Postoperative complications occurred in 32% of patients (33 of 103).  Common 
complications included:  anemia requiring transfusion(11), altered mental status (8), 
pneumonia (4), hardware complications requiring re-operation(3). Only one serious 
complication, renal failure, occurred. Average LOS for patients with a post-op 
complication was 5.1 ± 2.3 days vs. 2.9 ± 0.9 days for patients with no complication (p < 
0.001). Discharge to a sub-acute or nursing facility (p < 0.001) was significantly 
associated with increased length of stay.  
Levels fused was not predictive of LOS, possibly due to the skew towards one-
level cases in our sample.  
Conclusion:  
Patients that are older and have widespread systemic disease tend to stay in the 
hospital longer after surgery. Contrary to our expectations, no single comorbidity was 
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predictive of longer hospital stays. Heart disease was associated with a shorter length of 
stay, but this may have been due to a more extensive preoperative workup and closer 
medical management.  Intraoperative events did not affect LOS, however postoperative 
events did.  This data should prove useful for counseling patients and setting expectations 
of patients and the health care team.  
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Introduction: 
Decompression and instrumented fusion of the lumbar spine may be an 
appropriate option for certain conditions of the lumbar spine and is one of the most 
common procedures performed by spine surgeons. Average hospital stays after this 
procedure range from 3 to 6.7 days in previous studies. 27-29 This length of stay (LOS) 
variable is important from a patient perspective, and is an important factor in determining 
health care costs in patients undergoing spine surgery. Baseline costs of each extra day in 
the hospital run close to $1,000 dollars, 1 and inpatient hospital charges (not including 
instrumentation or surgical charges) are closely linked with LOS. 2 
In aggregate, treatments of lumbar pathology are associated with yearly costs 
approaching $50 billion in the United States alone. 30 Lumbar fusion costs represented 
about half of all spine surgery spending in 2003, 31 and the cost of hospitalization for 
spine surgery has been rising, with medical costs for lumbar fusion rising nearly 5-fold 
between 1992 and 2003. 31,32 These costs are not to be taken lightly.   
LOS is important to consider for reasons other than cost.  The importance of 
optimizing patient experience has clearly been receiving greater attention.  It has been 
shown that preoperative counseling before orthopedic procedures can reduce patient 
stress, leading to a faster recovery and shorter hospitalization. 3 Further, increased LOS 
has been associated with adverse outcomes such as hospital acquired infections 4,5 and 
increased risk of deep vein thrombosis (DVT). 6-8 These are intermediate variables on the 
pathway to potentially life-threatening outcomes. Moreover, longer LOS consumes 
physician time and decreases a department’s potential surgical volume. Knowledge of the 
factors determining LOS can help surgeons guide treatment and preoperative 
	  	  
8	  
expectations, and help patients and their families plan postoperative care and return to 
function.  
Many independent variables have been shown to influence LOS. Preoperative 
variables associated with increased LOS include: increased age 33, morbid obesity 34, 
diabetes 35, metabolic syndrome, 36 opioid use, 37 greater number of comorbid conditions, 
37 and unemployment, 37  Perioperative variables associated with increased LOS include: 
use of fibrin sealant, 1 open as opposed to minimally invasive surgery, 38 adverse 
intraoperative events, 39 fluids administered, 40 and drain use. 1 Postoperative variables 
including blood transfusion and complications have also been associated with increased 
LOS. 29 
Multivariate analysis is a powerful tool used to separate confounding variables 
that are often incorrectly believed to individually be potential outcome predictors.  In the 
spine literature, such multivariate analyses have been reported for LOS with minimally 
invasive lumbar spine surgery (MIS) and revision spine surgery. 29,40 For MIS patients, a 
number of perioperative factors including blood loss, longer surgical time, and crystalloid 
administration were associated with a stay greater than 24 hours, while age was found to 
be the only significant predictor of longer hospital stays following revision surgery. To 
our knowledge, LOS has yet to be considered as the dependent variable in a multivariable 
analysis for traditional, open lumbar fusion. 
The purpose of the present study is to identify variables via multivariate analyses 
that predict a longer hospital stay after open elective posterior lumbar fusions. We hope 
this information will be useful for guiding patient selection, preoperative counseling, and 
postoperative decision-making.   
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Methods: 
Patients who underwent posterior lumbar fusion surgery at a single institution 
between January of 2010 and June of 2012 were identified and their electronic medical 
records and charts were reviewed. All procedures were consecutively performed by one 
of three fellowship-trained orthopedic spine surgeons at our institution. This study 
received approval from our Human Investigation Committee.  
Patients treated with a combined anterior/posterior approach, patients treated with 
minimally invasive techniques, or patients requiring more than 3 levels of 
instrumentation were excluded. Trauma cases were also excluded.  
Demographic data collected included: gender, age, body mass index (BMI), 
presence or absence of smoking / alcohol / opiate / or illicit drug use, marital status, and 
employment status. Workers compensation information and patient race were not 
collected.   
Other pre-operative variables recorded included previous lumbar surgery, levels 
instrumented, American Society of Anesthesiologists (ASA) score, and history of major 
medical comorbidities (diabetes, hypertension, malignancy, pulmonary disease, or heart 
disease). Diabetes and hypertension were determined by a history of medication 
treatment for these conditions or by findings during the primary care preoperative 
assessment. Malignancy was defined as either a current or previous history of treatment 
with radiation or chemotherapy for a malignant tumor. Pulmonary disease was defined as 
asthma requiring hospitalization, chronic obstructive pulmonary disease, chronic 
bronchitis, or a history of pulmonary embolism. Heart disease was defined as a history of 
atrial fibrillation, murmur, arrhythmia, myocardial infarction, coronary artery disease, 
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mitral valve prolapse, or congestive heart failure.  In order to determine whether a 
confluence of comorbidities in a patient might affect LOS, patients with greater than 3 
comorbidities (hypertension, diabetes, morbid obesity, heart disease and pulmonary 
disease) were labeled as patients with multiple comorbidities or “high risk” for our 
analyses. 
Intraoperative variables recorded included operating room time (the number of 
minutes the patient spent in the operating room), and surgery time (the number of 
minutes from the first incision to placement of the postoperative dressing after closure), 
use of colloids, amount of crystalloids administered, estimated blood loss, use of a 
surgical drain, and any operative complications.  
Post-operative variables recorded included days until drain was removed (if used), 
transfusion of any blood products, return to surgery, any other notable postoperative 
events, discharge destination (home without services, home with services, or sub-acute 
care/nursing facility), and LOS. Postoperative pain control such as patient-controlled 
analgesia, narcotic use, or spinal anesthetic was not considered. Return to surgery 
occurred due to instrumentation complications discovered postoperatively. A “notable 
postoperative event” was defined as any adverse event noted in the chart that required 
further evaluation and treatment by either the orthopedic service or another service. 
Examples of notable postoperative events include well established complications like 
pneumonia, urinary tract infection, and renal failure as well as other issues including 
anemia requiring transfusion, altered mental status, cardiac complications, severe ileus, 
and severe hypertension.  
LOS was defined as days after surgery that patient was discharged and was 
recorded as an integer. As such, no distinction was made between a discharge in the 
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morning or afternoon and each additional day represents a new calendar day, and not 
necessarily an additional 24-hour period. Any patients discharged on the day of surgery 
were recorded as a “0” day length of stay. 
As with most centers, day of discharge was determined based on patients medical 
and rehabilitation status. Although it is difficult to delineate specific numeric criteria for 
discharge, it is standard practice that the medical service and rehabilitation service both 
weigh in to determine appropriateness for discharge based on established practice 
patterns.  
 
Statistical Analysis  
The extended stay cohort was determined by taking all patients with a LOS at 
least one standard deviation more than the mean. Based on this, bivariate independent 
samples t-tests were performed for all variables comparing the normal stay cohort to the 
extended stay cohort.  
For multivariable analysis, LOS was treated as a continuous variable, rather than 
the binary outcome used above. Multivariable linear stepwise regression was performed 
with LOS as a continuous dependent variable for two cohorts of independent variables: 
preoperative and perioperative (which encompassed both intra- and postoperative 
variables). "Notable postoperative events” were not included in the multivariate model as 
controls for associations between pre and perioperative variables and LOS because 
notable postoperative events were considered to be on the casual pathway between these 
variables and LOS. The purpose of this study was to identify pre and perioperative 
variables associated with LOS in general, not necessarily those independent of any 
adverse events. For example, if someone with COPD got postoperative pneumonia and 
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that caused an increased LOS, we wanted to count that as an association between COPD 
and LOS. If we had controlled for the development of pneumonia, then we would not be 
not be identifying this event as an association between COPD and LOS. Separately, 
“notable postoperative events” was analyzed as the dependent variable for the 
preoperative cohort variables.  As a stepwise regression, a series of iterative analyses 
were performed, excluding predictors by declining p-value until only variables with p < 
0.2 remained as the final model covariates. The final regression was performed with these 
variables, with p < 0.05 indicating statistical significance.  
Pierson bivariate cross-correlation analysis was performed on all independent 
variables found to be significantly associated with LOS to determine whether any of 
these factors were related. Two-sided p-values < 0.05 were considered statistically 
significant in all analyses.  
All statistical analyses were performed using SPSS software (SPSS Inc., Chicago, 
IL). 
 
 
Results: 
One hundred and three posterior lumbar fusions were identified for analysis and 
met inclusion / exclusion criteria. The average length of stay was 3.6 ± 1.8 days (mean ± 
standard deviation) and median length of stay was 3 days. Based on these results, an 
extended LOS was defined as five days or greater (patients who stayed ~ greater than 1 
standard deviation longer than the mean). Based on this cutoff, 79% (81 of 103) of 
patients had a regular LOS (four days or less) and 21% (22 of 103) had an extended LOS 
(five days or more). This data is depicted in Figure 1. 
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The female/male ratio was 1.4 and average age was 60.9 ± 13.6 years. Number of 
levels fused were 70 one-level, 26 two-level, and 7 three-level. Of these, 58 cases were 
primary surgeries and 45 were revision surgeries. LOS did not differ significantly 
between primary and revision cases (p = 0.996), although revision cases were associated 
with significantly longer surgical times (208 ± 70 min vs. 177 ± 47 min, p = 0.007).   
 Comorbid conditions included diabetes (n = 24, 23%), hypertension (n = 64, 
62%), morbid obesity (n= 17, 16.5%), pulmonary disease (n=21, 21%) and heart disease 
(n = 27, 26%). The “high risk” cohort was comprised of 24 patients (23.3%).  
Intraoperative complications were encountered for seven patients (7%): six dural 
tears and one pedicle fracture, all of which were recognized and corrected during the 
procedure. These patients stayed in the hospital longer (4.4 ± 1.5 days) than patients 
without intraoperative complications (3.5 ± 1.8 days), though the difference was not 
statistically significant (p = 0.125).   
Notable postoperative events were encountered for 33 patients (32%). Of these 
patients, 18 had a stay of 5 days or longer. Average LOS for these patients was 
significantly longer (5.1 ± 2.3 days vs. 2.9 ± 0.9 days) than for patients with no 
postoperative events (p < 0.001). Notable postoperative events included anemia requiring 
transfusion (11), altered mental status (8), pneumonia (4), return to OR due to construct 
complication (3), cardiac complications (3), urinary tract infection (2), severe ileus (2), 
and one each of severe asymptomatic hypertension, hypovolemia, renal failure, renal 
insufficiency, urinary retention, and respiratory complications requiring bilevel positive 
airway pressure. One patient was forced to wait in the hospital for 2 days while waiting 
for an open nursing care facility bed.  
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Each of the above variables was assessed as independent variables with bivariate 
t-tests, with >4 days considered as extended LOS (Table 1). Female gender (p = .030), 
ASA score (p= 0.043), discharge to a nursing home/subacute facility (p = 0.046), and 
identifiable postoperative events (p < 0.001) were significantly different between the 
normal and extended LOS cohorts. 
Identifiable postoperative events were assessed individually to determine which 
of those factors was responsible for driving a longer LOS. Patients experiencing any 
postoperative event were associated with a significantly longer hospital stay than patients 
not experiencing any event.  (Table 2)  
Of course, independent analyses can over or under estimate the impact of 
individual variables based on patterns of covariance. Thus, multivariable linear stepdown 
regression with LOS as a continuous variable was performed for both preoperative and 
perioperative factors. Based on this, the preoperative variables found to be associated 
with LOS were age (p= 0.038, β = .209) and ASA score (p= 0.001, β = .334).  
Paradoxically, history of heart disease was associated with a shorter hospital stay (p = 
0.005, β =  -.301). The only perioperative variable found to be associated with increasing 
LOS was discharge destination (p < 0.001, β = .376) (Table 3). No significant cross-
correlative relationships among these significant variables were found. Furthermore, 
discharge destination was also not associated with any of the preoperative variables 
examined.  
Once again, it should be noted that notable postoperative events were not included 
in the multivariate analysis of the factors effecting LOS because of concern they would 
wash out other lesser, but significant variables. Separate regression analysis found no 
preoperative variables to be predictive of these notable postoperative events.   
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Figure 1: 
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Table 1:Demographic, Preoperative, and Perioperative Factors and Their Association With LOS 
Variable LOS N Mean P 
95% Confidence Interval 
Lower Upper 
Sex   (Male =1, 
Female =0) 
Normal 81 .47 
   Extended 22 .23 0.030 0.025 0.459 
Age Normal 81 60.49    Extended 22 62.45 0.539 -8.382 4.461 
Levels Fused Normal 81 1.37    Extended 22 1.45 0.598 -0.406 0.238 
Pre-op 
Narcoticsa 
Normal 81 .44    
Extended 22 .41 0.772 -0.210 0.281 
Revision 
Surgerya       
Normal 81 .44 
   Extended 22 .41 0.772 -0.210 0.281 
BMI Normal 81 29.11    Extended 22 30.62 0.394 -5.105 2.072 
Diabetesa Normal 81 .23    Extended 22 .23 0.944 -0.202 0.217 
Hypertensiona Normal 81 .60    
Extended 22 .68 0.510 -0.311 0.158 
Morbid Obesitya Normal 81 .14    
Extended 22 .27 0.201 -0.351 0.077 
Pulmonary 
Diseasea 
Normal 81 .19    
Extended 22 .27 0.417 -0.305 0.130 
Heart Diseasea Normal 81 .30    Extended 22 .14 0.085 -0.023 0.343 
High Riska Normal 81 .23    
Extended 22 .23 0.944 -0.202 0.217 
Malignancya Normal 81 .10    
Extended 22 .05 0.349 -0.060 0.167 
Smokinga Normal 80 .41    
Extended 22 .45 0.732 -0.290 0.206 
Alcohola Normal 81 .63    
Extended 22 .55 0.631 -0.270 0.439 
ASA Normal 81 2.38    
Extended 22 2.64 0.043 -0.499 -0.009 
Joba Normal 76 .37    
Extended 21 .33 0.826 -0.289 0.359 
Marrieda Normal 81 .69    
Extended 21 .71 0.841 -0.254 0.208 
EBL (mL) Normal 75 330.73    
Extended 22 403.41 0.320 -218.406 73.055 
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Perioperative 
Transfusiona 
Normal 81 .19    
Extended 22 .32 0.239 -0.359 0.093 
Table 1. (Continued) 
Variable LOS Cohort N Mean P 
95% Confidence Interval 
Lower Upper 
Crystalloid  
Administered 
(mL) 
Normal 69 2306.52    
Extended 19 2623.68 0.149 -754.841 
120.51
6 
Colloid Usea Normal 81 .20    
Extended 22 .23 0.772 -0.237 0.178 
Drain Usea Normal 81 .73    
Extended 22 .68 0.683 -0.184 0.277 
Drain Duration 
(days) 
Normal 56 2.36    
Extended 12 2.58 0.309 -0.682 0.229 
Surgery Time 
(min) 
Normal 80 185.30    
Extended 22 210.50 0.088 -54.400 4.000 
OR Time (min) Normal 80 263.88    
Extended 22 287.36 0.150 -55.896 8.919 
Post-op 
complicationa 
Normal 81 .19 
   Extended 22 .82 0.000 -0.826 -0.440 
Discharge 
Destinationb 
Normal 81 .72    
Extended 22 .36 0.046 0.006 0.699 
Significance is determined with equal variance not assumed.                                                                                             
aYes = 1, No = 0                                                                                                                                                                                
b Home = 1, Subacute Care/Nursing Facility = 0 
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Table 2: Identifiable Postoperative Events Associated With a 
Significantly Longer LOS  
Variables N LOS Stdev P 
Total patientsa 33 5.09 2.25 <0.001  
 Anemia 11 3.82 0.87 .002 
  Delirium 8 7.71 2.69 <0.001 
  Pneumonia 4 7.00 2.16 <0.001 
 Return to OR 3 5.33 1.15 <0.001 
 Cardiac 3 6.00 3.46 <0.001 
 Other 11 4.45 1.92 <0.001 
a = All patients with an identifiable postoperative event. Note: 
Some patients had more than one event. P-values are in 
comparison to patients with no postoperative events.  
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Table 3: Variables Significantly Associated With an Extended LOS 
by Multivariate Analysis 
Variables 
Standardized 
Coefficients 
(Beta) P 
95% CI 
Lower 
Bound 
Upper 
Bound 
Preoperative         
 Age .209 .038 .002 .055 
  ASA .334 .001 .441 1.785 
  Heart -.301 .005 -2.069 -.387 
Perioperative     
  Discharge to 
subacute/nursing 
.376 .000 .664 2.150 
CI indicates confidence interval; ASA, American Society of 
Anesthesiologists. 
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Discussion: 
LOS after surgical intervention is clearly of significant importance from a patient 
and systems perspective.  The purpose of this study was to determine pre- and 
perioperative variables that significantly affect LOS in patients undergoing elective, open 
lumbar posterior instrumented fusion.  
Two studies in the spine literature have performed multi-variate analyses to 
determine pre- and perioperative variables associated with LOS. Zheng et al. 
retrospectively reviewed 112 patients undergoing revision surgery for posterior lumbar 
decompression and instrumented at a single institution between 1992 and 1999. 29 
Average length of stay was 6.0 ± 2.4 days and increasing age was the only significant 
predictor of a longer hospital stay. Unemployment accompanying three or more comorbid 
conditions and complications were associated with longer LOS as well.  
The other study was a retrospective cohort study of 104 patients undergoing 
minimally invasive transforaminal lumbar interbody fusions (MIS TLIF). 40 In this study, 
Siemenow et al. reported an average length of stay of 2.3 ± 1.2 days. Patients in the 
extended stay cohort (>24 hours) had significantly higher estimated blood loss, longer 
surgical time, received more crystalloids, had higher total fluids, lower end of case 
temperature, lower hemoglobin during hospitalization, and lower pre-op narcotic use. 
Multiple regression demonstrated that post-operative creatinine, visual analogue scale 
(VAS) score, intra-operative colloids, fluids input at the end of the case, crystalloid to 
colloid ratio, fluid balance, post-op oxycontin use, mean percentage of FiO2, and pre-
operative hemoglobin were all significant predictors of increased LOS. One of 
Siemenow’s interesting findings was that higher pre-op narcotic use was associated with 
a shorter length of stay, in contrast to their original expectation that dependence on 
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painkillers preoperatively would make pain management postoperatively more difficult. 
In explaining their findings, they hypothesized that the use of pre-operative narcotics 
must provide a “protective” effect on pain pathways, reducing the normal pain responses 
provoked by the surgical procedure. This effect, however, was not seen in our study. 
To our knowledge, we performed the first multivariate analyses evaluating 
preoperative and perioperative factors associated with hospital LOS after open lumbar 
decompression and instrumented fusion for all comers, which is one of the most common 
types of surgical intervention on the lumbar spine.  We evaluated 103 patients who 
underwent surgery between January 2010 and June 2012 at a single academic institution 
by one of three fellowship trained orthopedic spine surgeons.  
For posterior lumbar fusions, we typically tell our patients to plan for 
approximately a three-day stay. Our study does, in fact, support this-the average length of 
stay was 3.6 ± 1.8 days, with a median stay of 3 days. (Figure 1) Further, if we define 
extended LOS as greater than one standard deviation from the norm, an extended LOS is 
five days or more. Based on this, 21% of our patients had an extended LOS.   
Multivariable regression determined that the preoperative variables associated 
with increasing hospital stay were age and ASA score. The only perioperative factor 
determined by regression analysis to be associated with increasing LOS was discharge 
destination, but cause and effect for this association can be questioned. Of course, 
identifiable postoperative events affect LOS, but were not included in the multivariate 
analysis because of its strong and potentially confounding association with LOS. Patients 
with an identifiable postoperative event stayed at the hospital a significantly longer 
period of time than those who did not experience any issue. Events such as delirium (7.7 
± 2.7 days), pneumonia (7.0 ± 2.2 days), return to OR (5.33 ± 1.15 days), and cardiac 
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complications (6.0 ± 3.5 days) were drivers behind this difference, while anemia 
requiring transfusion (3.82 ± 0.87) played a lesser but still significant role. (Table 2) On 
regression analysis, no preoperative variables were found to be significantly predictive of 
postoperative adverse events.  This could suggest that factors leading to these 
complications are complex in nature and may largely take place during the perioperative 
period. Of course, some clinically important associations may also have been missed due 
to the small sample size of this study. 
We found it interesting that no specific pre-operative comorbidity was found to be 
associated with an LOS in our multivariate analyses. It is likely that many of these factors 
did not have a large enough effect size to be found significant in this analysis. Higher 
numbers might have shown other factors to be significant, but the effect size would not 
be expected to be clinically significant if this was the case. Even when comorbidities 
were combined to identify “high risk” patients (three or more comorbidities), we could 
not find an association with LOS. Age and ASA score were the two preoperative factors 
that were found to be associated with increasing  LOS.  Possibly there are general health 
variables associated with both age and ASA score that were not well accounted for by the 
specific preoperative comorbidities captured in our analyses.  
These results are consistent with previous findings for open revision spine surgery 
and for total knee and total hip arthroplasty patients. 29,41,42 Older and sicker patients are 
more likely to stay in the hospital longer, while surgeon- and hospital-related factors have 
little effect.   
The result that a history of heart disease associated with a shorter LOS was an 
unexpected finding of this study. One potential explanation could be found in the use of 
diuretics in heart failure patients to lower volume load. Excess volume administration and 
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fluid balance after spine surgery has been shown to lead to more complications and a 
longer hospital stay 40,43,44-it is possible that regular therapy given to heart disease patients 
lowers this fluid balance and allows them to leave the hospital sooner. More likely, 
however, is that the shorter LOS seen in these patients is due to a more extensive 
preoperative workup and closer medical management as a result of their pre-existing 
condition. These patients tend to be followed by two services postoperatively, allowing 
for greater fine-tuning of their hospital course and a faster discharge home.  
Postoperatively, patients discharged to a nursing or subacute care facility were 
more likely to stay in the hospital longer than patients returning home, with or without 
services. However, it is difficult to determine the directionality of this relationship and 
whether it is causative or associative. Do factors leading to a longer LOS drive discharge 
to nursing facility? Or do patients being sent to a nursing facility have characteristics that 
make them stay in the hospital longer?  It has been shown in total joint arthroplasty that 
patients that end up in rehabilitation facilities post-discharge are older, more likely to live 
alone, and have more co-morbid conditions. 45 However, we found no association 
between discharge to a subacute care facility and any preoperative factor. Additionally, it 
is not uncommon for patients to be kept in the hospital while waiting for a bed to open up 
at their discharge location. However, in this study, we could only identify this to have 
happened to one patient, who incurred a two-day wait once ready for discharge. It should 
also be noted that some insurance providers require a 2-3 day postoperative hospital stay 
before approving discharge to a subacute facility. This requirement has the potential to 
bias our results, although the “extended LOS” was considered >4 days for this study. 
Therefore, the “extended LOS” variable should be capturing patients that are remaining 
in the hospital for a reason other than needing to meet insurance requirements (just a 2-3 
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days stay) for postoperative care placement. Ultimately it is likely that patients with 
postoperative complications requiring longer LOS were preferentially discharged to a 
rehabilitation facility for further subacute follow-up.  
Limitations of this study include its retrospective nature and sample size. 
Furthermore, cases were skewed towards one-level procedures. An ideal study would 
have matched numbers of one, two, and three level surgeries. Still, stratifying this 
variable in our regression analysis should have helped to minimize this potential source 
of bias. Additionally, variables such as race, workers compensation, and insurance 
provider were not controlled for in the analysis. Other potential limitations include that 
the study was performed at a single institution, although this could be considered a 
strength because surgeon and hospital related cofounders are controlled. This study also 
uses data representing surgeries performed by three different surgeons. Despite attempts 
to stratify other confounding factors, surgeon techniques and personal preferences could 
have played a role in determining LOS. Finally, even though LOS is a continuous 
variable and is treated as such in our analysis, it was recorded as an integer in our 
database. As a result, surgeries or discharges occurring on the same day were treated 
equally, whether occurring at 8AM or 8PM. However, differences in discharge time of 
day seem more often related to systems / rides issues than true medical considerations 
from our experience.   
Understanding the risk factors that lead to increased hospital stay is crucial. 
Consideration of these factors could aid surgeons in patient selection, treatment choice, 
and preoperative counseling. Additionally, patients and their families can use this 
information to help schedule time off of work, arrange for transportation, and set-up post-
discharge care. To our knowledge, this is the first study that has considered which factors 
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predict LOS following posterior lumbar spinal fusion. This study has identified several 
patient factors: age, ASA score, history of heart disease and discharge to a 
subacute/nursing facility, that are all associated significantly with hospital stay. Although 
it is questionable whether any of these factors are modifiable, their effect on LOS must be 
considered before every surgery. The finding that a history of heart disease is associated 
with a shorter LOS has important implications that warrant more in depth consideration 
in future studies as this may be related to more extensive preoperative workup and closer 
medical management that might benefit all patients. 
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Part 2:	  Factors Affecting Length of Stay and Complications Following Elective Anterior 
Cervical Discectomy and Fusion: A Study of 2,164 Patients from The ACS NSQIP 
Database  
Abstract: 
Introduction:  
Elective anterior cervical discectomy and fusion (ACDF) is a commonly 
performed spinal surgery, renowned for its efficacy and safety. Many variables affect 
postoperative complications and hospital stay following this operation. The effect of 
individual preoperative factors on LOS and complications has been evaluated in small-
scale studies. Large database analysis with multivariate analysis of these variables has not 
been reported.   
Purpose: 
To determine factors independently associated with increased length of stay 
(LOS) and complications following ACDF in order to facilitate preoperative planning 
and setting of realistic expectations for patients and providers. 
Methods: 
The American College of Surgeons-National Surgical Quality Improvement 
Program's participant-use file was queried between the years of 2007 and 2011 for 
patients undergoing ACDF procedures. Pre-, peri-, and postoperative variables associated 
with postoperative complications and LOS were collected for 2164 patients. Significant 
predictors of postoperative complications and LOS were determined by multivariate 
regression. 
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Results: 
Average LOS was 2.0 ± 4.0 days (mean ± SD) with a range of 0 to 103 days. By 
multivariate analysis, age ≥ 65, functional status, transfer from facility, preoperative 
anemia, and diabetes were the preoperative factors predictive of extended LOS. Major 
complications, minor complications, and extended surgery time were the perioperative 
factors associated with increased LOS.  The elongating effect of these variables was 
determined, and ranged from 0.5-5.0 days.   
71 (3.3%) had a total of 92 major complications, including return to OR (40), 
venous thrombotic events (13), respiratory (21), cardiac (6), mortality (5), sepsis (4), and 
organ space infection (3). Multivariate analysis determined ASA score ≥ 3, preoperative 
anemia, age ≥ 65, extended surgery time and male gender to be predictive of major 
complications (odds ratios ranging between 1.756-2.609) 
No association found between levels fused and LOS or complications. 
Conclusion: 
Extended LOS following ACDF is associated with factors including age, anemia, 
and diabetes, as well as the development of postoperative complications. One in 33 
patients develops a major complication post-operatively, which are associated with an 
increased LOS of 5 days. 
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Introduction 
Anterior cervical discectomy and fusion (ACDF) has become increasingly 
popular due to its excellent and reliable outcomes, fast recovery, and lack of morbidity 
relative to the posterior approach. 46,47 The number of ACDF procedures performed in the 
United States increased nearly 8-fold between 1990 and 2004, with over 700,000 of these 
procedures performed during this time period. 48,49  
As utilization has increased, length of stay (LOS) and postoperative complication 
rates have decreased and (LOS from 5.17 days to 2.38 days and complication rates from 
4.36% to 3.03%), despite increases in medical comorbidities and age of patients. 48,50 
These variable are certainly inter-related with post-operative complications associated 
with longer LOS, 49 and longer LOS predisposing to complications such as hospital-
acquired infection and DVT. 4-8 
Many independent variables have individually been shown to influence LOS in all 
types of spine surgery patients. Preoperative variables associated with increased LOS 
include: age, 33 morbid obesity, 34 diabetes, 35 metabolic syndromes, 36 opioid use, 
increased number of comorbidities, and unemployment. 37 Operative variables associated 
with a longer hospital stay include: open surgery, 38 use of bone morphogenic protein, 51 
intraoperative complications, 39 excess fluid administration, 40 and drain use. 1 
Postoperative variables including blood transfusion and complications have also been 
associated with increased LOS. 29 
Multivariate analysis analyzing factors associated with prolonged LOS after 
ACDF is sparse. One study found preoperative variables such as older age and female 
gender, as well as postoperative complications such as cardiac, urinary and pulmonary 
issues to be associated with extended LOS. 52 Another study found preoperative coronary 
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artery bypass or stent, chronic renal disease, and preoperative opioid use correlated with 
the increased LOS typically seen in unemployed patients as compared to employed 
patients. 37 Post-operative complications were not considered. Finally, one large database 
study with a focus on hospital charges and demographics found male gender, black or 
Hispanic race, Medicare or Medicaid insurance, higher Charlson Comorbidity Index 
(CCI) score, and traumatic spine injury to be predictive of extended LOS. 53 
Complications were not considered. 
Many prior studies have looked at factors affecting long-term outcomes in 
patients who after ACDF. 47,54-60 Short-term complications after ACDF range from 1.6% 
to 31.0%, (partially affected by how “complications” are defined). 37,49,52,61-67  Short-term 
mortality has been reported between 0.1% and .3%.  49,54,62,66   Several studies have 
examined preoperative factors significantly associated with the occurrence of 
perioperative complications in all cervical spine surgeries, but did not attempt to 
differentiate between approaches and techniques in their analysis. 66,68-70 Others have 
examined preoperative factors responsible for postoperative outcomes like dysphagia, 
aspiration, and complications associated with BMP usage following ACDF. 51,71,72 
However, multivariate analysis determining which preoperative factors are associated 
with serious postoperative complications has not been performed. 
According to one study, inpatient hospital charges for this procedure can vary 
between $15,113 and $76,687, a variation that is largely attributed to variations in length 
of LOS (which is linked to complications). 2 Additionally, longer LOS increases 
physician time and resource utilization. Knowledge of the factors affecting complications 
and LOS may help surgeons guide treatment and preoperative expectations. Preoperative 
counseling before orthopedic procedures has been shown to reduce patient stress, 
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resulting in faster recovery, and facilitating discharge. 3  
As there are only a few small studies that address factors affecting LOS and risk 
of complications in ACDF patients, and these studies have differing results, it would be 
valuable to further characterize these factors on a larger, contemporary cohort. To our 
knowledge, no study has used these variables as dependent outcomes in a multivariate 
analysis model. This study’s objective is to elucidate which factors significantly 
contribute to extended LOS and increased complications and after ACDF. 
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Methods: 
Data Source 
The National Surgical Quality Improvement Program (NSQIP) began in 1994 as a 
quality improvement initiative within the Veteran’s Administration (VA) healthcare 
system. 73 The program was expanded to the private sector in 1999 after success within 
the VA. 74 The private sector NSQIP, referred to as ACS NSQIP, is a multi-center 
database that is available to participating hospitals in the United States. 
In the ACS NSQIP, more than 135 preoperative, perioperative, and 30-day 
postoperative variables are prospectively sampled from patient medical records, operative 
reports, as well as patient interviews. The patients are identified prospectively and 
randomly sampled. Outcomes data are collected throughout the 30-day postoperative 
period, even after patient discharge from the hospital. 
 
Data collection 
The study population was drawn from the NSQIP participant-use data files for 
2005 to 2010. Overall, this contains information on 1,334,886 patients from 258 
hospitals. ACDF cases were identified based on Current Procedural Terminology codes 
(CPT 22551, 22554) for anterior cervical fusion in any of the 21 CPT input categories 
available in NSQIP. Due to the change in CPT coding for anterior cervical fusion and 
discectomy in 2011, 75 cases with CPT code 22551 were relatively rare in our dataset.  
To optimize capture of patients undergoing anterior fusion, CPT code 63075 
(anterior discectomy) was included in our anterior cervical fusion cohort. Careful review 
of CPT codes in NSQIP showed that many cases with the anterior discectomy CPT code 
had additional codes indicating fusion (bone graft, instrumentation, etc.) indicating that 
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the discectomy occurred with fusion despite the absence of the specific anterior cervical 
fusion codes (22551, 22554). There were some cases in which only CPT 63075 was listed 
but because NSQIP requires only a singly primary code field per case, it is possible that 
associated codes were not always included. Given that cervical discectomy rarely occurs 
without fusion, we thought it justifiable to include those cases with primary CPT code of 
63075 in our cohort. 
Cases involving concomitant posterior cervical arthrodesis, thoracic or lumbar 
spine surgery, or any other unrelated procedures were excluded from analysis. 
 
Independent Variables 
Independent variables in this study included preoperative factors (patient 
demographics and medical comorbidities) and perioperative factors.  
Patient demographics included gender, age, obesity (defined in this study as any 
patient with a body mass index (BMI) ≥ 30 (kg/m2), smoking history within the past year, 
functional status (partially or totally dependent), and transfer status (home or care 
facility). Variables such as race, employment status, and workers compensation were 
considered in the analysis. 
Functional status is determined by patients’ abilities to perform activities of daily 
living (ADLs). Independent patients require no assistance in performing ADLs, while 
partially dependent patients and totally dependent patients require some level of 
assistance, and were grouped together for purposes of analysis. Transfer status is 
determined by whether the patient was admitted directly from home or from an outside 
facility such as a nursing home or subacute rehab.   
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Other preoperative variables collected include American Society of 
Anesthesiologists (ASA) score and a history of common medical comorbidities: diabetes, 
cardiovascular, pulmonary, hepatic, renal, neurological, preoperative anemia, and a 
history of bleeding disorder. 
A cardiovascular comorbidity was defined as congestive heart failure (CHF) 
within 30 days before surgery, a myocardial infarction (MI) in the 6 months before 
surgery, history of previous percutaneous coronary intervention (PCI), previous cardiac 
surgery, angina within one month prior to surgery, history of revascularization or 
amputation due to peripheral vascular disease, and extremity rest pain or gangrene. 
Pulmonary comorbidity was defined as ventilator dependence, history of severe chronic 
obstructive pulmonary disease (COPD), or current pneumonia. Hepatic insufficiency was 
defined as the presence of ascites or esophageal varices. Renal insufficiency was defined 
as acute renal failure or current dialysis. Finally, a neurological comorbidity was defined 
as impaired sensorium, coma longer than 24 hours, hemiplegia, paraplegia, quadriplegia, 
tumor involving the central nervous system (CNS), and history of transient ischemic 
attack (TIA) or cerebrovascular accident  (CVA). Preoperative anemia was defined as 
any patient entering surgery with a hematocrit <36. Of note, 200 patients did not have a 
hematocrit value on record in the database. A bleeding disorder was defined as any 
patient with a risk of excessive bleeding in the setting of an endogenous blood clotting 
element deficiency (hemophilia and thrombocytopenia), vitamin K deficiency, or on 
anticoagulants or antiplatelet agents. Chronic aspirin therapy is not included in this 
category. Chronic steroid use (regular use within 30 days before admission) was also 
assessed. 
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Operative time was the only intraoperative variable included in our analysis. The 
intraoperative “transfusion” variable was excluded from the analysis because over half of 
the values were unreported.  
Outcome variables 
The study endpoints were LOS, major complications, and infectious 
complications. LOS was defined as the number of days from the operation to discharge. 
For example, discharge the day after surgery was categorized as a LOS of 1 day.   
Major complications were defined as any organ space infection, respiratory 
complication (pneumonia, unplanned intubation, ventilator dependence), cardiac 
complication (cardiac arrest, MI), sepsis or septic shock, pulmonary embolism (PE), deep 
vein thrombosis (DVT), acute renal failure, return to the operating room (OR), or death. 
Infectious postoperative complications included urinary tract infections (UTI) and 
superficial or deep incisional infections. Infections are defined in the NSQIP database 
using Center for Disease Control classifications. 76 In this study, patients with superficial 
or deep incisional infections were combined into a single group of wound infections.  
Statistical analysis 
SPSS v.19 (IBM, Chicago, IL) was used for all statistical analysis. Patient 
demographics, the prevalence of comorbidities, mean operative time, number of operated 
levels, and mean LOS were calculated. Extended operative time was defined as 
operations longer than the 75th percentile. Rates of major and infectious complications as 
well as LOS were determined for the study population overall, and stratified by age 
bracket, American Society of Anesthesiologist (ASA) class, and the various demographic 
and comorbidity variables. Student t test and Chi-square test were used for discrete and 
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categorical variables, respectively, and analysis of variance (ANOVA) for comparisons 
across three or more groups.  
For major and infectious complications, bivariate regressions were performed 
with demographic, comorbidity, and intraoperative variables. Adjusted odds ratios and 
95% confidence intervals (CI) were calculated for both outcome variables. Predictors 
significant to p < .10 were carried forward into a multivariate logistic regression model to 
determine independent associations to developing a major or infectious complication, 
with clinical covariates. A total of 14 variables were incorporated in the multivariate 
model for major complications. These were age, preoperative anemia, transfer status 
(from home vs. care facility), history of diabetes, preoperative functional health status, 
preoperative cardiac or pulmonary or neurological comorbidity, a history of bleeding 
disorder, ASA class, type of anesthesia (regional vs. general anesthesia), intraoperative 
blood transfusion, wound class, and operative time. Eight variables were incorporated in 
the multivariate model for incisional wound complications: patient sex, transfer status 
(home vs. care facility), a history of current smoking, preoperative pulmonary 
comorbidity, preoperative anemia, BMI more than 30 kg/m2, intraoperative blood 
transfusion, and operative time. 
For the LOS outcome variable, a similar process of bivariate egressions with 
demographic, comorbidity, and intraoperative variables was performed. Predictors 
significant to p < .10 were carried forward into a multivariate linear regression model to 
determine the adjusted change in LOS, in days, for each of the included predictors.  
 Throughout the study, two-tailed p values of < .05 were considered 
statistically significant. 
 
	  	  
36	  
Results: 
This study identified 2,164 patients who underwent an ACDF between the years 
of 2005 and 2010. Single level fusions were performed for 1,839 (85%), and multi level 
fusions were performed for 325 (15%). Average LOS was 1.99 ± 3.914 (mean ± SD) with 
a range of 0 to 103 days. Figure 1 is a histogram showing the distribution of patients per 
length of stay. 
Clinical characteristics of the patient population, including demographics and 
comorbidities are found in Table 4. Analysis of each of these factors’ non-adjusted 
association with LOS, major complications, and infectious complications can be found in 
Table 5. 
When evaluating LOS, multivariate analyses revealed the factors shown in Table 
6 to be significant predictors of extended LOS when controlling for other variables.  
Preoperative variables associated with extended LOS included age ≥ 65, functional 
status, transfer from care facility, history of diabetes, and preoperative anemia. 
Perioperative factors associated with extended LOS include operative time > 171 min 
(>75th percentile), and both major and infectious complications. ASA score was not 
found to be a significant factor by multivariate analysis. The effect of each of the variable 
identified here had defined effects on extending the LOS that ranged from half a day to 
five days.   
Table 7 details the incidence and type of major and infectious complications 
following ACDF. Overall, 71 (3.30%) patients experienced a total of 92 major 
complications, and 27 (1.25%) patients experienced 27 infectious complications. 
Multivariate analyses revealed the variables shown in Table 8 to be significant 
predictor of complications when controlling for the other variables.  Preoperative factors 
	  	  
37	  
associated with major complications included age ≥ 65, male gender, preoperative 
anemia, and ASA ≥ 3. Operative time >171 min (>75th percentile), was also predictive of 
a major complication. No variables were found to be significantly associated with 
infectious complications.  
In order to better counsel our patients for two important preoperative variables, 
age and ASA scores, each factor was broken down into brackets and analyzed using 
ANOVA (Table 9). These findings show that patients in the older age brackets (65-74 
years and ≥ 75 years) and with higher ASA scores can be expected to experience more 
major complications and a significantly longer LOS. 
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Table 4: Clinical characteristics of ACDF patient population 
 Variable   N Percent 
Total patients  2164 100% 
Gender 
  
 
 
Male 1057 49.1% 
 
Female 1107 50.9% 
Age 
  
 
 
<65 1849 84.4% 
 
≥65 315 15.6% 
BMI 
  
 
 
<30 1232 57.3% 
 
≥30 924 42.7% 
Impaired Functional status  
 
No 2082 96.4% 
 
Yes 80 3.7% 
Transfer status 
 
 
 
No 2143 99.1% 
 
Yes 21 0.9% 
Smoking 
 
 
 
No 1414 65.3% 
 
Yes 750 34.7% 
Diabetes 
 
 
 
No 1890 87.3% 
 
Yes 274 12.7% 
Cardiovascular comorbidity 
 
 
 
No 2035 94.0% 
 
Yes 129 6.0% 
Pulmonary comorbidity 
 
 
 
No 2087 96.4% 
 
Yes 77 3.6% 
Hepatic insufficiency 
 
 
 
No 2163 100.0% 
 
Yes 1 0.0% 
Renal insufficiency 
 
 
 
No 2161 99.9% 
 
Yes 3 0.1% 
Neurological comorbidity 
 
 
 
No 1984 91.7% 
 
Yes 180 8.3% 
Chronic steroid use 
 
 
 
No 2107 97.4% 
 
Yes 57 2.6% 
Preoperative anemia  
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No 1782 90.8% 
 
Yes 181 9.2% 
Bleeding disorder 
 
 
 
No 2134 98.6% 
 
Yes 30 1.4% 
ASA classification 
 
 
 
1 108 5.0% 
 
2 1255 58.0% 
 
3 750 34.7% 
 
4 49 2.3% 
ASA score 3/4 
  
 
 
No 1365 63.0% 
 
Yes 799 37.0% 
Operation time > 75th percentile (171 min) 
 
No 1627 75.2% 
 
Yes 537 24.8% 
Number of levels 
 
 
 
1 1839 85.0% 
 
2 309 14.3% 
 
3 16 0.7% 
Multiple levels 
 
 
 
No 1839 85.0% 
 
Yes 325 15.0% 
BMI = Body Mass Index; ASA = American Society of Anesthesiologists 
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Table 5: Clinical characteristics of patient population and univariate association with LOS, major 
complications, and infectious complications 
 Variable   
 
LOS (days) 
Major 
complication 
Infectious 
complication 
Gender 
 
 
  
 
Male 2.2 ± 5.1 4.35% 1.04% 
 
Female 1.8 ± 2.3 2.26% 1.45% 
 
p 0.061 0.006a 0.397 
Age 
 
 
  
 
<65 1.7 ± 2.1 2.43% 1.30% 
 
>65 3.6 ± 8.7 8.25% 0.95% 
 
p <0.001a <0.001a 0.610 
BMI 
 
 
  
 
<30 2.1 ± 4.9 3.49% 1.14% 
 
>30 1.8 ± 2.0 2.92% 1.41% 
 
p 0.095 0.462 0.576 
Impaired Functional status 
 
No 1.8 ± 3.5 2.88% 1.25% 
 
Yes 6.2 ± 8.8 12.50% 1.25% 
 
p <0.001a <0.001a 0.999 
Transfer status  
  
 
No 1.9 ± 3.8 3.13% 1.21% 
 
Yes 7.3 ± 10.9 19.05% 4.76% 
 
p <0.001a <0.001a 0.145 
Smoking  
  
 
No 2.0 ± 4.3 2.97% 1.20% 
 
Yes 2.0 ± 3.0 3.87% 1.33% 
 
p 0.741 0.266 0.794 
Diabetes  
  
 
No 1.9 ± 3.7 3.12% 1.11% 
 
Yes 2.7 ± 4.9 4.38% 2.19% 
 
p 0.001a 0.275 0.133 
Cardiovascular comorbidity  
  
 
No 1.9 ± 3.7 3.00% 1.23% 
 
Yes 3.2 ± 5.9 7.75% 1.55% 
 
p <0.001 a 0.003 a 0.750 
Pulmonary comorbidity  
  
 
No 1.9 ± 3.8 2.92% 1.25% 
 
Yes 3.7 ± 5.3 12.99% 1.30% 
 
p <0.001 a <0.001 a 0.967 
Hepatic insufficiency  
  
 
No 2.0 ± 4.0 3.28% 1.25% 
 
Yes 3.0 ± 0.0 0.000% 0.000% 
 
p 0.796 0.854 0.911 
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Renal insufficiency  
  
 
No 2.0 ± 3.9 3.29% 1.25% 
 
Yes 6.0 ± 5.0 0.00% 0.00% 
 
p 0.076 0.750 0.846 
Neurological comorbidity  
  
 
No 1.9 ± 3.7 2.87% 1.26% 
 
Yes 3.3 ± 5.5 7.78% 1.11% 
 
p <0.001 a <0.001 a 0.863 
Chronic steroid use  
  
 
No 2.0 ± 3.9 3.28% 1.23% 
 
Yes 2.5 ± 5.7 3.51% 1.75% 
 
p 0.342 0.922 0.727 
Preoperative anemia  
  
 
No 1.8 ± 2.2 2.92% 1.29% 
 
Yes 3.4 ± 5.6 8.84% 1.11% 
 
p <0.001 a <0.001 a 0.832 
Bleeding disorder  
  
 
No 2.0 ± 3.9 3.19% 1.22% 
 
Yes 3.4 ± 3.2 10.00% 3.33% 
 
p 0.047 a 0.038 a 0.300 
ASA score ≥ 3 
 
 
  
 
No 1.7 ± 3.8 1.54% 1.03% 
 
Yes 2.5 ± 4.0 6.26% 1.63% 
 
p <0.001 a <0.001 a 0.224 
Operation time > 75th percentile (171 min) 
 
No 1.8 ± 3.8 2.34% 1.17% 
 
Yes 2.7 ± 4.1 6.15% 1.49% 
 
p <0.001 a <0.001 a 0.560 
Number of levels  
  
 
1 2.0 ± 4.2 3.26% 1.25% 
 
2 2.0 ± 1.6 3.56% 1.29% 
 
3 1.6 ± 0.7 0.00% 0.00% 
 
p 0.896 0.734 0.901 
Multiple levels  
  
 
No 2.0 ± 4.2 3.26% 1.25% 
 
Yes 2.0 ± 1.6 3.38% 1.23% 
 
p 0.938 0.909 0.976 
BMI = Body Mass Index; ASA = American Society of Anesthesiologists 
a indicates statistical significance (p < 0.05) 
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Table 6: Significant Predictors of Extended LOS 
Variables 
Effect Change 
in LOS (± SE) P value 
Preoperative   
 
Functional status  3.3 ± 0.3 <.001 
 
Transfer status 2.1 ± 0.6 <.001 
 Preoperative anemia  0.8 ± 0.2 <.001 
 
Age ≥ 65  0.7 ± 0.2 <.001 
 
Diabetes 0.5 ± 0.2 .008 
Perioperative   
 Major complication  5.0 ± 0.3 <.001 
 Infectious complication  1.2 ± 0.5 .016 
 Operative time > 171 min  0.7 ± 0.1 <.001 
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Table 7: Major and infectious complications following ACDF 
 Total n = 2164 
Number of patients with ≥ 1 major complications 71 (3.30%) 
 
Total number of major complications 92 
  
Acute renal failure 0 (0.00%) 
  
Cardiac  6 (0.28%) 
  
Death 5 (0.23%) 
  
Organ space infection 3 (0.14%) 
  
Respiratory  21 (0.97%) 
  
Return to OR 40 (1.85%) 
  
Sepsis/septic shock 4 (0.18%) 
  
Venous thrombotic events  13 (0.60%) 
 
  
Number of patients with ≥ 1 infectious complications 27 (1.25%) 
 
Total number of infectious complications 27 
  
Surgical site infection 14 (0.65%) 
  
Urinary tract infection 13 (0.60%) 
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Table 8: Significant Predictors of Major Complications  
 
Odds Ratio 95% CI P value 
 
ASA ≥ 3 2.609 1.454-4.680 .001 
 Preoperative anemia  2.138 1.093-4.183 .026 
 
Age ≥ 65  2.110 1.191-3.738 .010 
 
Operative time > 171 min  2.095 1.237-3.548 .006 
 
Male gender  1.756 1.027-3.003 .040 
ASA = American Society of Anesthesiologists 
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Table 9: Complications and LOS by Age Bracket and ASA Score 
 Variable   
 
N LOS (days) Major complication 
Age Bracket 
 
 
  
 
<35 103 1.6 ± 3.1 1.94% 
 
35-44 400 1.5 ± 1.6 2.25% 
 45-54 789 1.7 ± 1.8 2.15% 
 55-64 555 1.9 ± 2.6 3.06% 
 65-74 248 2.9 ± 5.3 6.85% 
 ≥75 67 6.0 ± 15.7 13.43% 
 
p  <0.001* <0.001* 
ASA Score 
 
 
  
 
1 108 1.3 ± 2.5 1.85% 
 
2 1255 1.7 ± 3.9 1.51% 
 3 750 2.3 ± 3.4 5.47% 
 4 49 5.7 ± 8.4 18.37% 
 
p  <0.001* <0.001* 
ASA = American Society of Anesthesiologists 
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Discussion 
General 
 ACDF is one of the most commonly performed spinal surgeries due to its 
favorable outcomes and safety. Previous studies have reported on the relatively short 
LOS and low associated morbidity. 46,47 The purpose of this study was to determine the 
variables linked with longer hospital stays and higher incidence of complications 
following this operation and to quantify the effect of these variables. Both LOS and 
complications are closely related and of significant importance from both the patient and 
surgeon’s perspective. 
Several previous studies have performed multi-variate analyses to determine pre- 
and perioperative variables associated with longer LOS following ACDF. Arnold et al. 
retrospectively reviewed 108 elective ACDF patients with an average LOS of 1.98 ± 1.6 
days. Significant predictors included age > 50 and female gender, as well as 
postoperative cardiac, urinary, and pulmonary complications. 52 Meanwhile, Walid et al. 
in a study of 283 ACDF patients found that a history of previous coronary artery bypass 
or stent, chronic renal disease, and preoperative opioid use correlated with increased LOS 
seen in unemployed patients as compared to employed patients. 37 This study did not 
discuss post-operative complications. Limitations of both these analyses include small 
sample size from a single institution and retrospective data collection. Another recent 
analysis with similar demographics identified male gender, black or Hispanic race, 
Medicare or Medicaid insurance, higher Charlson Comorbidity Index (CCI) score, and 
traumatic spine injury as predictive of extended LOS. 53 This study, which used a 
different national database, the Nationwide Inpatient Sample, focused primarily on 
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demographics and finances, with no tracking or discussion of post-operative 
complications.  
Several studies have been performed characterizing complications following all 
types of cervical spine surgery. 66,68,70 In a 2013 study utilizing ACS NSQIP, Schoenfeld 
et al. analyzed factors leading to increased complications for 5,887 patients following all 
types of spine surgery cases. 69 Age, pulmonary comorbidities, BMI, history of infection, 
ASA ≥ 3, neurologic conditions, resident (i.e., trainee) involvement, and procedural times 
>75th percentile increased the risk of complications. No attempt was made to stratify by 
type of spine surgery with that study. The ACS NSQIP database has also been used to 
study outcomes like LOS and risk of complications in other orthopedic operations, such 
as hip and knee arthroplasty. 77-79  
To our knowledge, there are have not been other studies with multivariate 
analysis of factors associated with LOS and postoperative complications following 
ACDF which are based on large multicenter database cohorts. We evaluated 2,164 
patients who underwent ACDF at participating institutions between 2005 and 2010.  
 
Length of stay (LOS) 
For our elective ACDF procedures, patients are generally advised to expect a 
postoperative stay of one night in the hospital. This bore out to be true in this study, with 
the majority of the patients staying only one night in the hospital (LOS of one day), while 
the tail of the curve seen in Figure 1 lead to an average LOS of 1.99 ± 3.91 days, 
consistent with previously reported values. 50,52,53,66  
The important question addressed in this study is what variables were 
independently associated with longer hospital stay, and by how much.  Multivariable 
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regression determined that the preoperative factors leading to an extended LOS were 
functional status (extended LOS by an average of 3.3 days), transfer status (extended 
LOS by an average of 2.1 days), preoperative anemia (extended LOS by an average of 
0.8 days), age ≥ 65 (extended LOS by an average of 0.7 days), and diabetes (extended 
LOS by and average of 0.5 days).  Perioperative factors leading to an extended LOS were 
major complications (extended LOD by an average of 5.0 days), infectious complications 
(extended LOS by and average of 1.2 days), operative time greater than 171 minutes or 
the 75th percentile time of surgery (extended LOS by and average of 0.7 days).  
Increased age, functional status, and transfer status are descriptive variables that 
represent a baseline level of disability, and their association with extended LOS in this 
study confirms previous findings in the arthroplasty literature. 77-79 Meanwhile, diabetes is 
associated with poor wound healing, immune function, and complicates postoperative 
medical management, all issues that have previously been shown to put spine surgery 
patients at risk for a postoperative complication and extended LOS. 80  
Anemia is the one preoperative factor associated with extended LOS in this study 
that is potentially modifiable. Previously, anemia has been shown to be associated with 
increased risk of delirium, cardiac complications, mortality, infection, and major and 
infectious complications as well as extended LOS following spine surgery. 81-84 Further 
study is warranted regarding the merits and endpoints for treating anemia preoperatively.  
The finding that complications lead to a longer hospital stay was expected, as it is 
these endpoints and their medical management that are the chief impetus keeping patients 
from being discharged. Major complications are especially important, as they increase 
LOS by nearly 5 days. Fortunately, they are infrequent in nature as just 3.3% of patients 
undergoing ACDF in this study experienced such events. 
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Complications  
It is generally found that complication rates are low after ACDF.  This study 
found 1 in 33 to experience a major complication based on the definition used for this 
study.  
This finding is also in line with previously reported values in most studies. 48,49,66 
However, there is a wide variation in the incidence of complications reported by different 
studies, a variation that can largely be attributed to varying definitions of “complication” 
between studies. For instance, in their small, single institution study, Arnold et al. 
reported a significantly higher perioperative complication rate of 31%. 52 This higher 
complication rate can be mostly be attributed to altering definitions of “cardiac” and 
“pulmonary” complications, as well as the inclusion of relatively infectious 
complications such as postoperative pain, anxiety, and dysphagia.  
An important question addressed in this study is what variables were 
independently associated with increased risks of major complications by the 3.3% of the 
population that experienced them.  Multivariable regression determined that the factors 
associated with major complications were ASA ≥ 3 (increased risk of a major 
complication by 2.6 times), preoperative anemia (increased risk of a major complication 
by 2.1 times), age ≥ 65 years old (increased risk of a major complication by 2.1 times), 
operative time greater than 171 minutes or 75th percentile length of case (increased risk of 
a major complication by 2.1 times) and male gender (increased risk of a major 
complication by 1.8 times 
An extended operative time has previously been correlated with increased risk of 
complications and postoperative infection spine patients in the NSQIP database. 69 It is 
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likely that extended operative time represents more complicated, extensive surgery on 
more difficult patients. Thus it is not necessarily an endpoint in itself but a representation 
of the patient and case. Surgeon technique, experience, and teaching responsibilities 
could also play a role.  
 Levels fused had no effect on length of stay or complication rates in this study. In 
previous literature, higher rates of complication have been seen in patients with 
multilevel fusion presumably as a result of increasingly complex operation marked by a 
more extensive dissection, extended operating time, and increased blood loss. 85 The 
findings of our study point to an improved management of the ACDF patient, both 
intraoperatively and postoperatively, regardless of the number of levels fused.  
 
Study limitations, strengths and conclusions 
There are several limitations to the study. The primary limitation with using a 
large database such as the NSQIP is that procedure specific variables are not collected. 
For example, dysphagia, with rates quoted up to 30% 64 and other neurologic 
complications specific to ACDF were not specifically captured in the dataset analyzed.  
Further, certain variables such as preoperative anemia were missing for some of 
the patients enrolled in the dataset.  It is presumed that such variables may be missing 
because the clinician was not specifically worried about obtaining this data prior to the 
surgery for patients for whom this would be expected to be normal, but this is not spelled 
out.    
Despite its shortcomings, NSQIP is a large dataset that provides detailed clinical 
information on many patients from hospitals across the country, allowing for analysis of a 
broad cross-section of the population. The large number of patients in this dataset allows 
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for greater power and multivariate analyses that would not be possible from smaller 
cohort studies.  
A final limitation of this study is the inability to determine the insurance status of 
each patient. Some insurers require a 2-3 day stay before discharge to a subacute or 
nursing facility. Although ACDF is typically a low morbidity surgery not requiring 
further intensive rehab, this requirement could introduce some potential bias into our 
study results by increasing LOS for this subset of patients.  
Factors associated with increased LOS and complication risk following ACDF 
have been defined and quantified in this study. While it is questionable whether many of 
these factors are truly modifiable, each must be considering before surgery. Physicians 
and patients will hopefully be able to turn to the results of this analysis to set realistic 
expectations. Further investigation of the generalizability of large database studies such 
as this is encouraged. In addition, with preoperative anemia identified as a risk factor for 
extending LOS and major complications, potentially the ability to modify a factor such as 
this and the impact of potential improvement might be worthy of consideration and study.   
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Part 3: Iliac Crest Bone Graft Use in Spinal Fusion: Incidence and Short-term 
Postoperative Risk in a National Cohort 
Abstract:  
Introduction: 
The use of iliac crest bone graft (ICBG) in spinal fusion has been associated with 
increased surgical time, increased hospital length of stay (LOS), and donor site morbidity 
associated with the harvest procedure. Development of expensive bone graft substitutes 
has been predicated on these issues and usage of ICBG in spinal fusion has certainly 
decreased. However, there are no recent studies that report the incidence of ICBG use. 
Additionally, data on the effect of bone graft harvest on LOS and readmission rate is 
sparse, and multivariate analysis has not been used to control for confounding factors. 
Purpose:  
The current study uses a large, national database to compare outcomes for those 
receiving ICBG to those who did not using multivariate analysis to control for 
confounding factors.  
Methods: 
A retrospective review of prospectively collected data from the American College 
of Surgeons National Surgical Quality Improvement Project (ACS NSQIP) 2010-2012 
database was conducted. 
The database was queried for patients undergoing spinal fusion with or without 
ICBG using CPT codes. Bivariate and multivariate analyses were performed to determine 
the effect of harvesting ICBG on operative time, postoperative adverse events, LOS, and 
readmission while controlling for comorbidities, demographics, and approach.  
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Results: 
13, 927 patients undergoing spinal fusion were identified. Of these, only 820 
(5.9%) utilized ICBG. Rates varied between 3.4% and 12.4% depending on approach. 
Bivariate logistic regression (used for categorical variables) found the ICBG 
cohort was more likely to have a postoperative blood transfusion (11.6% vs. 5.5%, 
p<0.001). Bivariate linear regression (used for continuous variables) found the ICBG 
cohort to have an extended operative time (+36.0 min, p<0.001) and extended LOS (+0.6 
days, p<0.001). 
Multivariate analyses controlling for comorbidities, demographics, and approach 
determined postoperative blood transfusion (OR 1.5), extended operative time (+ 22.0 
min, p<0.001) and LOS (+0.2 days, p=0.037) to be significantly associated with ICBG 
use.  
No other adverse event was significantly associated with ICBG use.  Readmission 
rates were not significantly different. 
 
Discussion/conclusion: 
Current ICBG usage in spinal fusion is low, with rates between 3.4% and 12.4% 
depending on approach.   
The current study used a large national database cohort and confirmed ICBG use 
to be associated with extended operative time and postoperative blood transfusion on 
multivariate analysis. Extended LOS was seen in ICBG patients, but the effect size (+0.2 
days) is not clinically relevant. Serious adverse events, infection, extended LOS, and 
increased readmission rates were not independently associated with ICBG use. 
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Despite a clear movement towards more expensive bone graft substitutes, ICBG 
remains a safe method for promotion of fusion in spine surgery.  
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Introduction: 
Iliac crest bone graft (ICBG) is often considered to aid the progression of spinal 
fusion due to its osteoconductive, osteoinductive, and osteogenic properties. 9-11 
However, morbidity associated with the harvest of ICBG is of clinical concern.  
Postoperative donor-site pain is a commonly reported issue.  However, reported 
numbers significantly vary.  Acute pain has been reported in 2.8%-27.9% of patients 12-14 
and chronic pain in 2.4-60% of patients. 15-18 Some suggest that donor site pain concerns 
are overstated, and persistent pain may be partially attributed to the primary spinal 
pathology. 13,19,20  
Other reported potential problems with ICBG use include hematoma, infection, 
pelvic fracture, and nerve palsy. 14,17,21 Additionally, the increased blood loss, operating 
time and anesthesia time associated with the harvest procedure add additional risk to the 
surgery. 21-24 The potential for donor site morbidity following ICBG harvest has been 
used to help justify the usage of more expensive artificial bone graft substitutes, such as 
bone morphogenic protein (BMP). 86  
Length of stay (LOS) is another important outcome to consider. Total hospital 
costs have been closely linked to LOS in spine surgery patients. 87,88 Additionally, longer 
LOS increases resource utilization and increases risk for life-threatening complications 
such as hospital acquired infection 4,5 and deep vein thrombosis (DVT). 6,8,89 Patients 
receiving ICBG are theoretically at a risk for prolonged LOS, due to increased donor site 
morbidity and pain leading to increased postoperative care needs. Various small studies 
have reported differing results on increased LOS following the use of ICBG, although 
multivariate analysis to control for potentially confounding factors has not performed. 
19,21-26  
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Readmission rate is an additional outcome increasingly used as an indicator of 
quality of care. This occurs as new health care guidelines mandate fines, a loss or 
decrease of reimbursement for surgical patients readmitted within 30 days of surgery, or 
reduced reimbursement to hospitals with high readmission rates. 90-93 However, data is 
sparse regarding this outcome in spine surgery patients. 
This study seeks to characterize the short-term adverse events, LOS and 
readmission rates associated with ICBG use for spinal fusion. To our knowledge, no 
other study has performed multivariate analysis to control for confounding factors when 
reporting these results. In doing so we hope to gain further insight into the short-term 
morbidity caused by this technique while accounting for patient factors and operative 
approach.  
 
Methods: 
Data source 
This study used the American College of Surgeons National Surgery Quality 
Improvement Program (ACS NSQIP) database to determine the effect of ICBG use on 
adverse events, LOS, and readmission rates following spinal surgery.  
The ACS NSQIP is a prospective, risk-adjusted, multi-institutional outcomes 
program that began in 1994 in the Veteran’s Administration (VA) healthcare system, and 
was expanded in 1999 to include other high volume hospitals in the United States. 73,94 
The details of data collection, inclusion criteria, sampling procedures, and outcomes have 
been reported. 94,95 135 preoperative, perioperative, and 30-day postoperative variables 
are prospectively sampled from patient medical records, operative reports, and patient 
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interviews to evaluate 30-day risk-adjusted surgical outcomes. Outcomes are collected 
throughout the 30-day postoperative period, even after discharge. 
 
Data Collection 
 
We conducted a retrospective study using the ACS NSQIP database. Patients who 
underwent spine procedures from 2010 to 2012 were selected using the following Current 
Procedural Terminology (CPT) codes: anterior cervical discectomy and fusion (22551, 
22554, and 63075), anterior cervical corpectomy (63081), posterior cervical fusion 
(22600), posterior thoracic fusion (22610), anterior lumbar interbody fusion (22558), 
posterior lumbar interbody fusion (22612 and 22630). The number of levels was 
determined based on the presence of procedure-specific supplementary CPT codes for 
each additional level. 
Patients were separated based on the use of iliac crest bone graft with CPT codes 
20937 and 20938. Local autograft was not included in the ICBG cohort. Patients with 
multiple spinal procedures, spinal deformities, patients who underwent urgent or 
emergent surgery, and those with preexisting infection were excluded from analysis. 
 Among the variables available in the NSQIP are patient characteristics including 
sex, age, height, and weight. Body mass index (BMI) was calculated. The NSQIP also 
includes information on medical comorbidities and American Society of 
Anesthesiologists (ASA) class. A modified Charlson comorbidity index (CCI) 96 was 
calculated for each patient based on the available comorbidity data. Such modified CCIs 
have been shown to be similar in efficacy to the original CCI, 97,98 and the modified CCI 
employed in this study has been previously used with the ACS-NSQIP. 99 The 
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comorbidities used to determine the modified CCI included (followed by corresponding 
point values): myocardial infarction (1), congestive heart failure (1), peripheral vascular 
disease or rest pain (1), transient ischemic attack or cerebrovascular accident (1), chronic 
obstructive pulmonary disease (1), diabetes mellitus (1), hemiplegia (2), end stage renal 
disease (2), ascites or esophageal varices (3), and cancer (6). Finally, one point was added 
for each decade greater than 40 years of age. 
 
Adverse Events 
The NSQIP tracks patients for 23 individual adverse events in the first thirty 
postoperative days. A serious adverse event (SAE) was defined as the occurrence of any 
of the following: death, coma > 24 hours, on ventilator > 48 hours, unplanned intubation, 
stroke/cerebrovascular accident, pulmonary embolism, cardiac arrest, myocardial 
infarction, acute renal failure, sepsis, septic shock, wound disruption, deep surgical site 
infection, organ/space infection (other than surgical site), graft/prosthesis/flap failure, or 
return to the operating room. Minor adverse events (MAEs) included superficial surgical 
site infection, urinary tract infection, pneumonia, blood transfusion, progressive renal 
insufficiency, peripheral nerve injury, and DVT.  
The categories SAE and MAE are reported per patient, not per event. Thus, a 
patient with two different MAEs would count as only one in the total MAE category.  
 
Operative time and Length of Stay 
Operative time was defined as the time from surgical incision to wound closure in 
minutes. LOS was defined as calendar days from operation to hospital discharge, and 
recorded as an integer. No distinction was made between morning or afternoon discharge 
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or surgery, and each additional day may not represent an additional 24-hour period. 
Operative time and LOS were treated as continuous variables for analysis. 
 
Readmission 
Thirty-day readmission data in the NSQIP was first collected in 2011. For this 
study, readmission was defined as positive when a patient had an unplanned readmission 
one or more times. Readmission data is collected for the 30-day period following the 
operation, not from discharge. As such, patients with LOS > 10 days were excluded from 
the readmission analysis to allow for a large enough window to capture readmissions that 
occurred between discharge and 30 postoperative days. 
 
Analysis 
Statistical analyses were conducted using STATA® version 11.2 (StataCorp, LP, 
College Station, Texas, USA). All tests were two-tailed and the statistical difference was 
established at a two-sided α level of 0.05 (p < 0.05). Patients treated with or without 
ICBG were first compared by demographic and comorbidity variables using Pearson’s 
chi-squared test. 
 Percent of adverse events that occurred with or without ICBG were compared 
using bivariate and multivariate logistic regression, using non-ICBG cases as the 
reference. Multivariate logistic regression adjusted for demographic and comorbidity 
variables (age, sex, body mass index, ASA class, and modified CCI) and approach. 
Adverse events with at least one event in each cohort were compared. The continuous 
variables operative time and LOS were compared using bivariate and multivariate linear 
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regression. Readmission rates between the two groups were compared using bivariate and 
multivariate logistic regression.  
 
 
Results: 
 
This study identified 13,927 patients undergoing spinal fusion between the years 
of 2010 and 2012. Of these, 820 (5.9%) cases utilized ICBG. Clinical characteristics of 
the patient population, including demographics and comorbidities for the two cohorts can 
be found in Table 10. No significant baseline difference was seen for age, sex, BMI, 
ASA, or CCI. Only number of levels fused was found to be significantly different 
between the two cohorts, with ICBG cases more likely to be multi-level fusions (47.5% 
vs. 39.2%, p<0.001). However, overall, ICBG cases were still the minority in multilevel 
fusions (390 ICBG cases vs. 5,138 non-ICBG cases). 
The use of ICBG for each type of procedure is detailed in Table 11. Depending on 
the procedure, this ranged from 3.4% to 12.4% of cases utilizing ICBG.   
Bivariate logistic regression was used to test the association of ICBG with binary 
postoperative events (Table 12, bivariate columns).  No SAEs were found to be 
associated with the ICBG group.  There was an increase in aggregated minor adverse 
events for the ICBG group (OR=2.0, p<0.001) which seemed to be driven by only one 
significant minor adverse event which was blood transfusion (OR=2.3, p<0.001) 
Multivariate logistic regression analyses was then used to control for 
comorbidities, demographics, and approach (Table 12, multivariate columns).  Similar to 
the bivariate analyses, there were no differences in SAEs, but aggregated minor adverse 
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events (OR=1.4, p=0.008) and blood transfusions (OR=1.5, p=0.002) remained more 
common in the ICGB group.    
Of the study population, 411 (3.6%) of 11,086 patients with LOS ≤ 10 days were 
readmitted. Of these patients, 681 (6.1%) had ICBG. Rates of readmission were not 
significantly different between the groups on bivariate or multivariate analysis. 
It should be noted that the non-ICBG cohort was associated with 21 mortalities 
(0.2%) within 30 days of surgery, while the ICBG cohort was associated with 0 (0.0%). 
Because of the “0” value for the ICBG cohort, significance was unable to be determined.  
Bivariate linear regression was used to test the association between ICBG use and 
the continuous variables LOS and operative time (Table 13). The ICBG cohort was found 
to have an extended operative time (+36.0 min, p < 0.001) and extended LOS (3.1 ± 2.9 
days vs. 2.5 ± 3.5 days, p < 0.001) relative to those for whom ICBG was not utilized. 
Multivariate linear regression analysis controlling for comorbidities, demographics, and 
approach found extended operative time (+22 min, p<0.001) and LOS (+0.2 days, 
p=0.037) to be significantly associated with ICBG use. 
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    Table 10: Patient demographics and comorbidities 
  All Patients No ICBG ICBG p
 a 
Overall 13,927 13,107 (94.1%) 
820 
(5.9%)  
Age    0.686     18-39 11.5% 11.4% 12.2%      40-49 24.5% 24.5% 23.2%      50-59 30.3% 30.3% 29.0%      60-69 20.8% 20.7% 22.1%      ≥70 13.0% 13.0% 13.5%  
Male sex 46.6% 46.5% 47.3% 0.650 
Body mass index    0.155     18-25 21.6% 21.5% 23.0% 
     25-30 34.2% 34.1% 36.6%      30-35 24.9% 25.0% 22.9%      ≥35 19.3% 19.4% 17.5%  
ASA 3-4 39.6% 39.5% 40.9% 0.446 
Modified CCI    0.809    0-1 33.3% 33.3% 32.8%     2 26.8% 26.8% 26.2%     ≥3 39.9% 39.8% 41.0%   
Number of levels    <0.001 
   1 60.3% 60.8% 52.6%  
   2 28.4% 28.0% 34.8%  
   ≥3 11.3% 11.2% 12.7%   
a Bolding indicates significance 
ASA = American Society of Anesthesiologists Score, CCI = Charlson Comorbidity Index 
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    Table 11: Operative characteristics 
Procedure Total No ICBG ICBG 
Anterior cervical fusion 8,518 8,134 (95.5%) 384 (4.5%) 
Anterior cervical corpectomy 99 93 (93.9%) 6 (6.1%) 
Posterior cervical fusion 659 589 (89.4%) 70 (10.6%) 
Posterior thoracic fusion 177 155 (87.6%) 22 (12.4%) 
Anterior lumbar fusion 1,134 1,096 (96.7%) 38 (3.4%) 
Posterior lumbar fusion 3,340 3,040 (91.0%) 300 (9.0%) 
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  Table 12: Association of ICBG with adverse events and readmission in spine surgery patients 
  
Percent of 
non-ICBG 
cases with 
outcome 
Percent of 
ICBG cases 
with 
outcome 
Bivariate 
logistic 
regression  
Multivariate 
logistic 
regression  a 
  OR p OR p 
Serious adverse event 3.4% 4.2% 1.2 0.232 1.1 0.756 
Death 0.2% 0.0% - - - - 
Coma > 24 hours 0.1% 0.0% - - - - 
Ventilator > 48 hours 0.4% 0.2% 0.6 0.466 0.6 0.451 
Unplanned intubation 0.5% 0.6% 1.2 0.750 1.1 0.767 
Stroke/cerebrovascular accident 0.1% 0.0% - - - - 
Pulmonary embolism 0.3% 0.4% 1.3 0.698 1.0 0.938 
Cardiac arrest requiring CPR 0.1% 0.4% 2.7 0.116 1.6 0.135 
Myocardial Infarction 0.2% 0.2% 1.5 0.613 1.4 0.658 
Acute renal failure 0.1% 0.0% - - - - 
Sepsis 0.4% 0.5% 1.2 0.771 0.9 0.849 
Septic shock 0.1% 0.1% 1.5 0.720 1.0 0.977 
Return to the operating room 2.1% 2.7% 1.3 0.235 1.1 0.756 
Wound dehiscence 0.2% 0.2% 1.5 0.570 1.0 0.972 
Deep surgical site infection 0.4% 0.6% 1.7 0.240 1.3 0.580 
Organ space infection 0.1% 0.0% - - - - 
Graft/prosthesis/flap failure 0.1% 0.0% - - - - 
Minor adverse event 7.6% 14.0% 2.0 <0.001 1.4 0.008 
Superficial surgical site infection 0.7% 0.7% 1.1 0.838 0.8 0.639 
Urinary tract infection 1.0% 1.0% 0.9 0.833 0.7 0.432 
Pneumonia 0.7% 0.7% 1.1 0.859 1.0 0.932 
Blood transfusion 5.5% 11.6% 2.3 <0.001 1.5 0.002 
Progressive renal insufficiency 0.1% 0.1% 2.0 0.514 2.0 0.523 
Peripheral nerve injury 0.1% 0.2% 2.5 0.236 1.9 0.401 
DVT/thrombophlebitis 0.3% 0.6% 1.8 0.222 1.3 0.566 
Readmission b 3.5% 4.1% 1.2 0.417 1.0 0.995 
a Each line represents a separate multivariate analysis for each variable in order to give an adjusted OR 
and p-value by controlling for all demographics, comorbidities, and operative approaches found in 
Table 1 and Table 2. 
 b Readmission analysis used data from years 2011 and 2012 only and excluded patients with LOS >10 
days, leaving 11,086 patients for analysis. 411 [3.6%] of 11,086 patients were readmitted, and 681 
(6.1%) of 11,086 patients had ICBG. 
Bolding indicates significance 
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Table 13: Association of ICBG with operative time and length of stay in spine surgery patients 
  
  Non-ICBG 
Mean ± SD   
ICBG           
Mean ± SD 
Bivariate linear 
regression a 
Multivariate linear 
regression a 
 
 
Coef. p Coef. p 
 Operative time 149.0 ± 90.0 187.0 ± 95.0 +36.0 <0.001 +22 <0.001 
 Length of stay (days) 2.5 ±3.5 3.1 ± 2.9 +0.6 <0.001 +0.2 0.037 
 a Unstandardized coefficient represents unit change in the outcome variable if the predictor variable is 
positive. For example, a statistically significant coefficient of 36.0 for operative time means that on 
average, ICBG is associated with an increase in operative time of 36.0 minutes.       
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Discussion:  
Our study finds that ICBG is used in only 5.9% of fusions in current practice, 
with the value varying between 3-12% based on anatomic approach. Despite decreased 
utilization, ICBG continues to be considered the “gold standard” for achieving biologic 
union in spine fusion surgery. However, concerns for peri- and post-operative 
complications remain. The purpose of this study was to characterize the short-term 
adverse events, LOS, and readmission rates associated with ICBG use.   
Analyses of the morbidity associated with ICBG are becoming more challenging 
in modern clinical practice due to the decreased utilization of ICBG. However, the use of 
a national database has allowed for adequate numbers to support the analyses performed 
in the current study.  
 
Adverse Events: 
 Morbidity associated with the harvest procedure is often cited as a shortcoming of 
ICBG use. Economic analysis justifying use of expensive bone graft substitutes is 
predicated on this donor site morbidity. 86 Acute and chronic pain, increased blood loss, 
increased operating time, hematoma, infection, fracture and neurologic injury have been 
reported. 14,17,21-24 Meanwhile, other studies show no significant increase in postoperative 
morbidity. 13,19,21  
 The rates for AEs in the current study do fall within the ranges reported in the 
literature, supporting their validity. 19 Multivariate regression found ICBG use to be 
significantly associated with aggregated minor adverse events (14.0% vs. 7.6%), 
postoperative blood transfusion (11.6% vs. 5.5%), and extended operating time (+22.0 
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min). The significant increase in minor adverse events is attributed mostly to the increase 
in blood transfusions. 
  The need for perioperative transfusion in the ICBG cohort was the only specific 
postoperative adverse event found to be significantly different between groups in this 
study. The added soft tissue dissection, additional incisional site, and extended operative 
time associated with bone graft harvest may cause increased blood loss, leading to the 
need for transfusion. Additionally, in our study, the ICBG cohort had a higher percentage 
of multilevel fusion cases (47.5% vs. 39.2%), meaning larger incisions, longer surgeries 
and potentially more blood loss in that cohort. However, this effect size was small, and 
controlled for in multivariate analysis. Increased intraoperative blood loss for ICBG 
patients has previously been reported, 22,23,100,101 however few studies report on 
postoperative transfusion requirements. Of note, Radcliff et al. analyzed 354 patients 
from the spine patient outcomes research trial (SPORT) and found no increase in 
postoperative transfusions for ICBG use in lumbar spine fusion. 21  
 Extended operative time was also associated with ICBG use. This is likely 
secondary to the additional incision site, although the use of ICBG in more complex, 
multilevel cases is also a potential factor. In this study operating time was extended even 
when controlling for number of levels fused. An increase in operating time is important, 
as it can represent more anesthesia time for the patient. Additionally, increased operating 
time has previously been associated with postoperative complications and infections. 69 
 An important negative finding is that there was not an increase in infection rate in 
the ICBG group (at 30 day postoperative day follow up).  There was also not an increase 
in return to the operating room. 
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Finally, a post-operative mortality rate of 0.2% (21 cases) was seen in the non-
ICBG group, with 0% in the ICBG cohort. Despite this low rate, mortality in an elective 
procedure is serious enough to warrant further mention. Life threatening complications 
have been reported with the use of synthetic bone graft substitutes, like rh-BMP, 
especially with off-label use. 25 While we are unable to comment on the use of bone graft 
substitutes due to limitations in the NSQIP data reporting, ICBG use is not associated 
with additional risk of mortality in this cohort.  
 
Length of Stay 
 Extended LOS following ICBG use has been reported in several studies, although 
confounding factors were not controlled for. 19,26,101 LOS is an important marker of short-
term morbidity in these patients, as it is a reflection of the extra time needed to attend to 
immediate postoperative issues such as pain control, infection, and need for transfusion 
prior to discharge. As an endpoint, extended LOS also leads to increased costs and risk of 
serious complications. 4-6,8,89 
 The current study found LOS to be significantly longer in ICBG patients (+0.2 
days, p = 0.008) by multivariate analysis, although this statistical significance can largely 
be attributed to the high power of this study, rather than a large effect size. It is 
questionable whether an extended LOS of less than a quarter day is clinically significant. 
Still, as an overall average, it may be valuable as a marker representing increased 
requirements for postoperative care in the ICBG cohort. 
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Readmission Rate 
 Readmission rate has become an increasingly important outcome for surgeons and 
hospitals, as new health care laws begin to mandate decreased compensation and/or held 
reimbursements for patients readmitted with in 30 days of discharge. 90-93 Our study 
found no significant increase in readmission rates for ICBG patients within the 30 days 
post-surgery.  
Previous literature on the subject of readmission rates is limited, although 
growing. Patients with a higher Charlson Comorbidity Index are more likely to be 
readmitted within 30 days for all orthopedic procedures. 102 In spine surgery, variables 
that were not linked to ICBG have been linked to readmission within 30 days (such as 
infection, medical management, and planned staged procedures). 103,104 As these variables 
were not associated with the use of ICBG in the current study, it seems reasonable that no 
increase in readmission was associated with the use of ICBG in the current study.   
  
Study limitations, strengths and conclusions 
Several limitations exist for this study. Primarily, procedure specific variables are 
not available in national databases such as the NSQIP database used here. This includes a 
lack of information about the ICBG harvest procedure and non-coded specifics about the 
primary surgical site, both of which could have a clear confounding effect on the results.  
Postoperative pain data, which is clearly of interest in the discussion of ICBG, was also 
not available.  Additionally, readmissions are tracked until 30 days post-surgery, not 30 
days post-discharge. Thus, the readmission rate values reported in this study do not fully 
reflect 30-day readmissions, an important marker for new health care laws.  
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Despite several shortcomings, NSQIP is valuable as a database that captures 
clinical information, including 30-day postoperative outcomes, from many hospitals 
across the country, allowing for large-scale multivariate analyses with greater power than 
smaller cohort studies are able to generate.  
The effect of ICBG use on adverse events, LOS, and readmission rates in spine 
surgery was characterized and quantified in this study. It is of interest that only 5.9% of 
cases utilized ICBG in this national sample. Additionally, a greater percentage of ICBG 
cases are multilevel fusions (47.5% vs. 39.2%). Multivariate analyses controlling for 
comorbidities, demographics, approach and levels fused determined postoperative blood 
transfusion (OR 1.5), extended operative time (+ 22.0 min, p<0.001) and extended LOS 
(+0.2 days, p=0.037) to be significantly associated with ICBG use.  No other adverse 
event was significantly associated with ICBG use.  Readmission rates were not 
significantly different.  This data should be helpful in that it characterized the morbidity 
associated with ICBG in current clinical practice.   
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Conclusions: 
 
Understanding the risk factors that lead to postoperative complications and 
increased hospital stay is crucial. Knowledge of these factors could be useful for surgeons 
in patient selection, treatment choice, and preoperative counseling. Additionally, patients 
and their families can use this information to help schedule time off of work, arrange for 
transportation, and set-up post-discharge care.  In this study, we set out to characterize 
LOS and complications for two different spinal fusion approaches and one grafting 
technique, using both a local cohort and a national database.  
As study populations, both the local cohort and national database have varying 
strengths and weaknesses. Local cohorts are often small, making capturing and analyzing 
rare complications difficult. Single institution studies also have questionable external 
validity, although do allow for control of surgeon and hospital related cofounders and for 
detailed collection of patient factors, procedure details, and postoperative events. 
Meanwhile, the primary limitation with using a large database such as the NSQIP is that 
procedure specific variables are not collected. For example, dysphagia and other 
neurologic complications specific to ACDF were not captured in the dataset analyzed. 
Harvest site location and pain after ICBG usage was also not reported. Despite its 
shortcomings, NSQIP is a large dataset that provides detailed clinical information on 
many patients from hospitals across the country, allowing for analysis of a broad cross-
section of the population. The large number of patients in this dataset allows for greater 
power and multivariate analyses that would not be possible from smaller, local cohort 
studies.  
This is the first study to characterize factors predictive of extended LOS following 
posterior lumbar and anterior cervical fusion. Lumbar fusion patients that are older and 
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have widespread systemic disease tend have longer LOS, but no single comorbidity was 
predictive of LOS. After ACDF, 1 in 33 patients develops a major post-operative 
complication, which are associated with an increased LOS of 5 days. For each approach, 
it is questionable whether many of the predicting factors are truly modifiable, although 
each must be considered before surgery. Preoperative anemia was identified as a risk 
factor for extending LOS and major complications following ACDF, a potentially 
treatable, modifiable condition that may be worthy of future consideration and study. 
This is also the first study to characterize current ICBG usage rates and postoperative 
LOS and complications using a large, national database. Current ICBG usage in spinal 
fusion was demonstrated to be surprisingly low, with rates between 3.4% and 12.4% 
depending on approach.  Use of ICBG is associated with extended operative time, 
extended LOS, and postoperative blood transfusion, confirming prior studies. No 
significant postoperative complications were associated with graft harvest. 
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Figure Legend: 
Figure 1: Length of stay following lumbar spinal fusion.  
Histogram showing the distribution of patients per length of stay following lumbar 
fusion. An extended length of stay included all patients discharged after 5 or more days. 
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Figure 1: 
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Table 1:Demographic, Preoperative, and Perioperative Factors and Their Association With LOS 
Variable LOS N Mean P 
95% Confidence Interval 
Lower Upper 
Sex   (Male =1, 
Female =0) 
Normal 81 .47 
   Extended 22 .23 0.030 0.025 0.459 
Age Normal 81 60.49    Extended 22 62.45 0.539 -8.382 4.461 
Levels Fused Normal 81 1.37    Extended 22 1.45 0.598 -0.406 0.238 
Pre-op 
Narcoticsa 
Normal 81 .44    
Extended 22 .41 0.772 -0.210 0.281 
Revision 
Surgerya       
Normal 81 .44 
   Extended 22 .41 0.772 -0.210 0.281 
BMI Normal 81 29.11    Extended 22 30.62 0.394 -5.105 2.072 
Diabetesa Normal 81 .23    Extended 22 .23 0.944 -0.202 0.217 
Hypertensiona Normal 81 .60    
Extended 22 .68 0.510 -0.311 0.158 
Morbid Obesitya Normal 81 .14    
Extended 22 .27 0.201 -0.351 0.077 
Pulmonary 
Diseasea 
Normal 81 .19    
Extended 22 .27 0.417 -0.305 0.130 
Heart Diseasea Normal 81 .30    Extended 22 .14 0.085 -0.023 0.343 
High Riska Normal 81 .23    
Extended 22 .23 0.944 -0.202 0.217 
Malignancya Normal 81 .10    
Extended 22 .05 0.349 -0.060 0.167 
Smokinga Normal 80 .41    
Extended 22 .45 0.732 -0.290 0.206 
Alcohola Normal 81 .63    
Extended 22 .55 0.631 -0.270 0.439 
ASA Normal 81 2.38    
Extended 22 2.64 0.043 -0.499 -0.009 
Joba Normal 76 .37    
Extended 21 .33 0.826 -0.289 0.359 
Marrieda Normal 81 .69    
Extended 21 .71 0.841 -0.254 0.208 
EBL (mL) Normal 75 330.73    
Extended 22 403.41 0.320 -218.406 73.055 
Perioperative 
Transfusiona 
Normal 81 .19    
Extended 22 .32 0.239 -0.359 0.093 
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Table 1. (Continued) 
Variable LOS Cohort N Mean P 
95% Confidence Interval 
Lower Upper 
Crystalloid  
Administered 
(mL) 
Normal 69 2306.52    
Extended 19 2623.68 0.149 -754.841 
120.51
6 
Colloid Usea Normal 81 .20    
Extended 22 .23 0.772 -0.237 0.178 
Drain Usea Normal 81 .73    
Extended 22 .68 0.683 -0.184 0.277 
Drain Duration 
(days) 
Normal 56 2.36    
Extended 12 2.58 0.309 -0.682 0.229 
Surgery Time 
(min) 
Normal 80 185.30    
Extended 22 210.50 0.088 -54.400 4.000 
OR Time (min) Normal 80 263.88    
Extended 22 287.36 0.150 -55.896 8.919 
Post-op 
complicationa 
Normal 81 .19 
   Extended 22 .82 0.000 -0.826 -0.440 
Discharge 
Destinationb 
Normal 81 .72    
Extended 22 .36 0.046 0.006 0.699 
Significance is determined with equal variance not assumed.                                                                                             
aYes = 1, No = 0                                                                                                                                                                                
b Home = 1, Subacute Care/Nursing Facility = 0 
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Table 2: Identifiable Postoperative Events Associated With a 
Significantly Longer LOS  
Variables N LOS Stdev P 
Total patientsa 33 5.09 2.25 <0.001  
 Anemia 11 3.82 0.87 .002 
  Delirium 8 7.71 2.69 <0.001 
  Pneumonia 4 7.00 2.16 <0.001 
 Return to OR 3 5.33 1.15 <0.001 
 Cardiac 3 6.00 3.46 <0.001 
 Other 11 4.45 1.92 <0.001 
a = All patients with an identifiable postoperative event. Note: 
Some patients had more than one event. P-values are in 
comparison to patients with no postoperative events.  
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Table 3: Variables Significantly Associated With an Extended LOS 
by Multivariate Analysis 
Variables 
Standardized 
Coefficients 
(Beta) P 
95% CI 
Lower 
Bound 
Upper 
Bound 
Preoperative         
 Age .209 .038 .002 .055 
  ASA .334 .001 .441 1.785 
  Heart -.301 .005 -2.069 -.387 
Perioperative     
  Discharge to 
subacute/nursing 
.376 .000 .664 2.150 
CI indicates confidence interval; ASA, American Society of 
Anesthesiologists. 
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Table 4: Clinical characteristics of ACDF patient population 
 Variable   N Percent 
Total patients  2164 100% 
Gender 
  
 
 
Male 1057 49.1% 
 
Female 1107 50.9% 
Age 
  
 
 
<65 1849 84.4% 
 
≥65 315 15.6% 
BMI 
  
 
 
<30 1232 57.3% 
 
≥30 924 42.7% 
Impaired Functional status  
 
No 2082 96.4% 
 
Yes 80 3.7% 
Transfer status 
 
 
 
No 2143 99.1% 
 
Yes 21 0.9% 
Smoking 
 
 
 
No 1414 65.3% 
 
Yes 750 34.7% 
Diabetes 
 
 
 
No 1890 87.3% 
 
Yes 274 12.7% 
Cardiovascular comorbidity 
 
 
 
No 2035 94.0% 
 
Yes 129 6.0% 
Pulmonary comorbidity 
 
 
 
No 2087 96.4% 
 
Yes 77 3.6% 
Hepatic insufficiency 
 
 
 
No 2163 100.0% 
 
Yes 1 0.0% 
Renal insufficiency 
 
 
 
No 2161 99.9% 
 
Yes 3 0.1% 
Neurological comorbidity 
 
 
 
No 1984 91.7% 
 
Yes 180 8.3% 
Chronic steroid use 
 
 
 
No 2107 97.4% 
 
Yes 57 2.6% 
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Preoperative anemia  
 
No 1782 90.8% 
 
Yes 181 9.2% 
Bleeding disorder 
 
 
 
No 2134 98.6% 
 
Yes 30 1.4% 
ASA classification 
 
 
 
1 108 5.0% 
 
2 1255 58.0% 
 
3 750 34.7% 
 
4 49 2.3% 
ASA score 3/4 
  
 
 
No 1365 63.0% 
 
Yes 799 37.0% 
Operation time > 75th percentile (171 min) 
 
No 1627 75.2% 
 
Yes 537 24.8% 
Number of levels 
 
 
 
1 1839 85.0% 
 
2 309 14.3% 
 
3 16 0.7% 
Multiple levels 
 
 
 
No 1839 85.0% 
 
Yes 325 15.0% 
BMI = Body Mass Index; ASA = American Society of Anesthesiologists 
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Table 5: Clinical characteristics of patient population and univariate association with LOS, major 
complications, and infectious complications 
 Variable   
 
LOS (days) 
Major 
complication 
Infectious 
complication 
Gender 
 
 
  
 
Male 2.2 ± 5.1 4.35% 1.04% 
 
Female 1.8 ± 2.3 2.26% 1.45% 
 
p 0.061 0.006a 0.397 
Age 
 
 
  
 
<65 1.7 ± 2.1 2.43% 1.30% 
 
>65 3.6 ± 8.7 8.25% 0.95% 
 
p <0.001a <0.001a 0.610 
BMI 
 
 
  
 
<30 2.1 ± 4.9 3.49% 1.14% 
 
>30 1.8 ± 2.0 2.92% 1.41% 
 
p 0.095 0.462 0.576 
Impaired Functional status 
 
No 1.8 ± 3.5 2.88% 1.25% 
 
Yes 6.2 ± 8.8 12.50% 1.25% 
 
p <0.001a <0.001a 0.999 
Transfer status  
  
 
No 1.9 ± 3.8 3.13% 1.21% 
 
Yes 7.3 ± 10.9 19.05% 4.76% 
 
p <0.001a <0.001a 0.145 
Smoking  
  
 
No 2.0 ± 4.3 2.97% 1.20% 
 
Yes 2.0 ± 3.0 3.87% 1.33% 
 
p 0.741 0.266 0.794 
Diabetes  
  
 
No 1.9 ± 3.7 3.12% 1.11% 
 
Yes 2.7 ± 4.9 4.38% 2.19% 
 
p 0.001a 0.275 0.133 
Cardiovascular comorbidity  
  
 
No 1.9 ± 3.7 3.00% 1.23% 
 
Yes 3.2 ± 5.9 7.75% 1.55% 
 
p <0.001 a 0.003 a 0.750 
Pulmonary comorbidity  
  
 
No 1.9 ± 3.8 2.92% 1.25% 
 
Yes 3.7 ± 5.3 12.99% 1.30% 
 
p <0.001 a <0.001 a 0.967 
Hepatic insufficiency  
  
 
No 2.0 ± 4.0 3.28% 1.25% 
 
Yes 3.0 ± 0.0 0.000% 0.000% 
 
p 0.796 0.854 0.911 
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Renal insufficiency  
  
 
No 2.0 ± 3.9 3.29% 1.25% 
 
Yes 6.0 ± 5.0 0.00% 0.00% 
 
p 0.076 0.750 0.846 
Neurological comorbidity  
  
 
No 1.9 ± 3.7 2.87% 1.26% 
 
Yes 3.3 ± 5.5 7.78% 1.11% 
 
p <0.001 a <0.001 a 0.863 
Chronic steroid use  
  
 
No 2.0 ± 3.9 3.28% 1.23% 
 
Yes 2.5 ± 5.7 3.51% 1.75% 
 
p 0.342 0.922 0.727 
Preoperative anemia  
  
 
No 1.8 ± 2.2 2.92% 1.29% 
 
Yes 3.4 ± 5.6 8.84% 1.11% 
 
p <0.001 a <0.001 a 0.832 
Bleeding disorder  
  
 
No 2.0 ± 3.9 3.19% 1.22% 
 
Yes 3.4 ± 3.2 10.00% 3.33% 
 
p 0.047 a 0.038 a 0.300 
ASA score ≥ 3 
 
 
  
 
No 1.7 ± 3.8 1.54% 1.03% 
 
Yes 2.5 ± 4.0 6.26% 1.63% 
 
p <0.001 a <0.001 a 0.224 
Operation time > 75th percentile (171 min) 
 
No 1.8 ± 3.8 2.34% 1.17% 
 
Yes 2.7 ± 4.1 6.15% 1.49% 
 
p <0.001 a <0.001 a 0.560 
Number of levels  
  
 
1 2.0 ± 4.2 3.26% 1.25% 
 
2 2.0 ± 1.6 3.56% 1.29% 
 
3 1.6 ± 0.7 0.00% 0.00% 
 
p 0.896 0.734 0.901 
Multiple levels  
  
 
No 2.0 ± 4.2 3.26% 1.25% 
 
Yes 2.0 ± 1.6 3.38% 1.23% 
 
p 0.938 0.909 0.976 
BMI = Body Mass Index; ASA = American Society of Anesthesiologists 
a indicates statistical significance (p < 0.05) 
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Table 6: Significant Predictors of Extended LOS 
Variables 
Effect Change 
in LOS (± SE) P value 
Preoperative   
 
Functional status  3.3 ± 0.3 <.001 
 
Transfer status 2.1 ± 0.6 <.001 
 Preoperative anemia  0.8 ± 0.2 <.001 
 
Age ≥ 65  0.7 ± 0.2 <.001 
 
Diabetes 0.5 ± 0.2 .008 
Perioperative   
 Major complication  5.0 ± 0.3 <.001 
 Infectious complication  1.2 ± 0.5 .016 
 Operative time > 171 min  0.7 ± 0.1 <.001 
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Table 7: Major and infectious complications following ACDF 
 Total n = 2164 
Number of patients with ≥ 1 major complications 71 (3.30%) 
 
Total number of major complications 92 
  
Acute renal failure 0 (0.00%) 
  
Cardiac  6 (0.28%) 
  
Death 5 (0.23%) 
  
Organ space infection 3 (0.14%) 
  
Respiratory  21 (0.97%) 
  
Return to OR 40 (1.85%) 
  
Sepsis/septic shock 4 (0.18%) 
  
Venous thrombotic events  13 (0.60%) 
 
  
Number of patients with ≥ 1 infectious complications 27 (1.25%) 
 
Total number of infectious complications 27 
  
Surgical site infection 14 (0.65%) 
  
Urinary tract infection 13 (0.60%) 
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Table 8: Significant Predictors of Major Complications  
 
Odds 
Ratio 95% CI 
P 
value 
 
ASA ≥ 3 2.609 1.454-4.680 .001 
 Preoperative anemia  2.138 1.093-4.183 .026 
 
Age ≥ 65  2.110 1.191-3.738 .010 
 
Operative time > 171 min  2.095 1.237-3.548 .006 
 
Male gender  1.756 1.027-3.003 .040 
ASA = American Society of Anesthesiologists 
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Table 9: Complications and LOS by Age Bracket and ASA Score 
 Variable   
 
N LOS (days) Major complication 
Age Bracket 
 
 
  
 
<35 103 1.6 ± 3.1 1.94% 
 
35-44 400 1.5 ± 1.6 2.25% 
 45-54 789 1.7 ± 1.8 2.15% 
 55-64 555 1.9 ± 2.6 3.06% 
 65-74 248 2.9 ± 5.3 6.85% 
 ≥75 67 6.0 ± 15.7 13.43% 
 
p  <0.001* <0.001* 
ASA Score 
 
 
  
 
1 108 1.3 ± 2.5 1.85% 
 
2 1255 1.7 ± 3.9 1.51% 
 3 750 2.3 ± 3.4 5.47% 
 4 49 5.7 ± 8.4 18.37% 
 
p  <0.001* <0.001* 
ASA = American Society of Anesthesiologists 
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Table 10: Patient demographics and comorbidities 
  All Patients No ICBG ICBG p a 
Overall 13,927 13,107 (94.1%) 820 (5.9%)  
Age    0.686     18-39 11.5% 11.4% 12.2%      40-49 24.5% 24.5% 23.2%      50-59 30.3% 30.3% 29.0%      60-69 20.8% 20.7% 22.1%      ≥70 13.0% 13.0% 13.5%  
Male sex 46.6% 46.5% 47.3% 0.650 
Body mass index    0.155     18-25 21.6% 21.5% 23.0% 
     25-30 34.2% 34.1% 36.6%      30-35 24.9% 25.0% 22.9%      ≥35 19.3% 19.4% 17.5%  
ASA 3-4 39.6% 39.5% 40.9% 0.446 
Modified CCI    0.809    0-1 33.3% 33.3% 32.8%     2 26.8% 26.8% 26.2%     ≥3 39.9% 39.8% 41.0%   
Number of levels    <0.001 
   1 60.3% 60.8% 52.6%  
   2 28.4% 28.0% 34.8%  
   ≥3 11.3% 11.2% 12.7%   
a Bolding indicates significance 
ASA = American Society of Anesthesiologists Score, CCI = Charlson Comorbidity Index 
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Table 11: Operative characteristics 
Procedure Total No ICBG ICBG 
Anterior cervical fusion 8,518 8,134 (95.5%) 384 (4.5%) 
Anterior cervical corpectomy 99 93 (93.9%) 6 (6.1%) 
Posterior cervical fusion 659 589 (89.4%) 70 (10.6%) 
Posterior thoracic fusion 177 155 (87.6%) 22 (12.4%) 
Anterior lumbar fusion 1,134 1,096 (96.7%) 38 (3.4%) 
Posterior lumbar fusion 3,340 3,040 (91.0%) 300 (9.0%) 
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Table 12: Association of ICBG with adverse events and readmission in spine surgery patients 
  
Percent of 
non-ICBG 
cases with 
outcome 
Percent of 
ICBG cases 
with 
outcome 
Bivariate 
logistic 
regression  
Multivariate 
logistic 
regression  a 
  OR p OR p 
Serious adverse event 3.4% 4.2% 1.2 0.232 1.1 0.756 
Death 0.2% 0.0% - - - - 
Coma > 24 hours 0.1% 0.0% - - - - 
Ventilator > 48 hours 0.4% 0.2% 0.6 0.466 0.6 0.451 
Unplanned intubation 0.5% 0.6% 1.2 0.750 1.1 0.767 
Stroke/cerebrovascular accident 0.1% 0.0% - - - - 
Pulmonary embolism 0.3% 0.4% 1.3 0.698 1.0 0.938 
Cardiac arrest requiring CPR 0.1% 0.4% 2.7 0.116 1.6 0.135 
Myocardial Infarction 0.2% 0.2% 1.5 0.613 1.4 0.658 
Acute renal failure 0.1% 0.0% - - - - 
Sepsis 0.4% 0.5% 1.2 0.771 0.9 0.849 
Septic shock 0.1% 0.1% 1.5 0.720 1.0 0.977 
Return to the operating room 2.1% 2.7% 1.3 0.235 1.1 0.756 
Wound dehiscence 0.2% 0.2% 1.5 0.570 1.0 0.972 
Deep surgical site infection 0.4% 0.6% 1.7 0.240 1.3 0.580 
Organ space infection 0.1% 0.0% - - - - 
Graft/prosthesis/flap failure 0.1% 0.0% - - - - 
Minor adverse event 7.6% 14.0% 2.0 <0.001 1.4 0.008 
Superficial surgical site infection 0.7% 0.7% 1.1 0.838 0.8 0.639 
Urinary tract infection 1.0% 1.0% 0.9 0.833 0.7 0.432 
Pneumonia 0.7% 0.7% 1.1 0.859 1.0 0.932 
Blood transfusion 5.5% 11.6% 2.3 <0.001 1.5 0.002 
Progressive renal insufficiency 0.1% 0.1% 2.0 0.514 2.0 0.523 
Peripheral nerve injury 0.1% 0.2% 2.5 0.236 1.9 0.401 
DVT/thrombophlebitis 0.3% 0.6% 1.8 0.222 1.3 0.566 
Readmission b 3.5% 4.1% 1.2 0.417 1.0 0.995 
a Each line represents a separate multivariate analysis for each variable in order to give an adjusted OR and 
p-value by controlling for all demographics, comorbidities, and operative approaches found in Table 1 and 
Table 2. 
 b Readmission analysis used data from years 2011 and 2012 only and excluded patients with LOS >10 
days, leaving 11,086 patients for analysis. 411 [3.6%] of 11,086 patients were readmitted, and 681 (6.1%) 
of 11,086 patients had ICBG. 
Bolding indicates significance 
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Table 13: Association of ICBG with operative time and length of stay in spine surgery patients 
  
  Non-ICBG 
Mean ± SD   
ICBG           
Mean ± SD 
Bivariate linear 
regression a 
Multivariate linear 
regression a 
 
 
Coef. p Coef. p 
 Operative time 149.0 ± 90.0 187.0 ± 95.0 +36.0 <0.001 +22 <0.001 
 Length of stay (days) 2.5 ±3.5 3.1 ± 2.9 +0.6 <0.001 +0.2 0.037 
 a Unstandardized coefficient represents unit change in the outcome variable if the predictor variable is 
positive. For example, a statistically significant coefficient of 36.0 for operative time means that on 
average, ICBG is associated with an increase in operative time of 36.0 minutes.       
  
 
 
